EVIO (EVIO) 10-Q/A 16 Aug 18 2018 Q3 Quarterly report (amended) Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Jun. 30, 2018	Aug. 14, 2018
Document And Entity Information
Entity Registrant Name	EVIO, INC.
Entity Central Index Key	715,788
Document Type	10-Q
Document Period End Date	Jun. 30, 2018
Amendment Flag	false
Current Fiscal Year End Date	--09-30
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		20,098,235
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2,018

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($)	Jun. 30, 2018	Sep. 30, 2017
Current assets:
Cash	$ 1,254,443	$ 121,013
Accounts receivable, net of allowance of $128,237 and $74,782, respectively	300,215	229,564
Prepaid expenses	8,569	169,557
Other current asset	122,225	7,438
Note receivable, current portion	100,000	100,000
Total current assets	1,785,452	627,572
Property and equipment, net of accumulated depreciation of $457,629 and $213,447, respectively	1,871,229	547,073
Security deposits	580,506	92,892
Note receivable, net of current portion	1,200,000	1,200,000
Deposit, related party	180,000
Intangible assets, net of accumulated amortization, net of accumulated amortization of $369,828 and $189,475, respectively	1,808,877	592,260
Goodwill	6,343,593	2,958,137
Total assets	13,769,657	6,017,934
Current liabilities
Accounts payable and accrued liabilities	825,445	773,053
Client deposits	117,268	119,281
Deferred revenue	30,573	40,800
Interest payable	379,332	133,697
Capital lease obligation, current	153,555	37,990
Derivative liability	1,579,258	294,637
Convertible notes payable, net of discounts of $0 and $208,680, respectively	500,000	1,212,720
Loans payable, current, net of discounts of $74 and $127,662, respectively	1,011,986	1,503,545
Loans payable, related party, current	255,915	312,855
Total current liabilities	4,853,332	4,428,578
Convertible debentures payable, net of discounts of $5,682,529 and $0, respectively	900,471
Capital lease obligation, net of current portion	276,866	52,777
Loans payable, net of current portion	46,448	59,832
Convertible loans payable, related party, net of current portion, net of discounts of $26,660 and $0, respectively	58,340
Loans payable, related party, net of current portion, net of discounts of $30,465 and $42,044, respectively	1,083,530	1,251,306
Total liabilities	7,218,987	5,792,493
Stockholders equity
Common Stock, Par Value $.0001, 1,000,000,000 authorized; 19,719,903 and 10,732,922 issued and outstanding at June 30, 2018 and September 30, 2017, respectively	1,972	1,073
Additional Paid In Capital	18,073,657	7,657,982
Other Comprehensive Income	(317,132)
Accumulated Deficit	(13,458,754)	(7,592,371)
Total stockholders'equity	4,300,348	67,317
Non-controlling interest	2,250,322	158,124
Total equity	6,550,670	225,441
Total liabilities and stockholders' equity	13,769,657	6,017,934
Series A Preferred Stock [Member]
Stockholders equity
Convertible Preferred Stock
Series B Preferred Stock [Member]
Stockholders equity
Convertible Preferred Stock	500	500
Series C Preferred Stock [Member]
Stockholders equity
Convertible Preferred Stock	50	50
Series D Preferred Stock [Member]
Stockholders equity
Convertible Preferred Stock	$ 55	$ 83

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)	Jun. 30, 2018	Sep. 30, 2017
Current assets:
Accounts receivable, net of allowance	$ 128,237	$ 74,782
Property and equipment, net of accumulated depreciation	457,629	213,447
Intangible assets, net of accumulated amortization	369,828	189,475
Current liabilities
Discounts on convertible notes payable	0	208,680
Loans payable, current, net of discounts	74	127,662
Noncurrent liabilities
Convertible debentures payable, net of discounts	5,682,529	0
Discount on related party current	26,660	0
Loans payable, related party	$ 30,465	$ 42,044
Stockholders' equity
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	1,000,000,000	1,000,000,000
Common stock, shares issued	19,719,903	10,732,922
Common stock, shares outstanding	19,719,903	10,732,922
Series A Preferred Stock [Member]
Stockholders' equity
Convertible Preferred Stock, Par Value	$ 0.0001	$ 0.0001
Convertible Preferred Stock, Shares Authorized	1,850,000	1,850,000
Convertible Preferred Stock, Shares Issued	0	0
Convertible Preferred Stock, Shares Outstanding	0	0
Series B Preferred Stock [Member]
Stockholders' equity
Convertible Preferred Stock, Par Value	$ 0.0001	$ 0.0001
Convertible Preferred Stock, Shares Authorized	5,000,000	5,000,000
Convertible Preferred Stock, Shares Issued	5,000,000	5,000,000
Convertible Preferred Stock, Shares Outstanding	5,000,000	5,000,000
Series C Preferred Stock [Member]
Stockholders' equity
Convertible Preferred Stock, Par Value	$ 0.0001	$ 0.0001
Convertible Preferred Stock, Shares Authorized	500,000	500,000
Convertible Preferred Stock, Shares Issued	500,000	500,000
Convertible Preferred Stock, Shares Outstanding	500,000	500,000
Series D Preferred Stock [Member]
Stockholders' equity
Convertible Preferred Stock, Par Value	$ 0.0001	$ 0.0001
Convertible Preferred Stock, Shares Authorized	1,000,000	1,000,000
Convertible Preferred Stock, Shares Issued	552,500	832,500
Convertible Preferred Stock, Shares Outstanding	552,500	832,500

UNAUDITED CONSOLIDATED STATEMEN

UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Revenues
Testing services	$ 595,701	$ 767,873	$ 2,172,061	$ 2,081,877
Consulting services	38,637	9,345	141,453	196,520
Total revenue	634,338	777,218	2,313,514	2,278,397
Cost of revenues
Testing services	754,647	592,273	2,115,487	1,717,997
Consulting services	4,729	33,373	93,721	65,378
Depreciation and amortization	70,075	28,618	154,894	74,968
Total cost of revenues	829,451	654,264	2,364,102	1,858,343
Gross margin	(195,113)	122,954	(50,588)	420,054
Operating expenses
Selling, general and administrative	1,989,753	582,113	5,023,122	1,478,007
Depreciation and amortization	125,500	40,413	266,656	114,793
Total operating expenses	2,115,253	622,526	5,289,778	1,592,800
Loss from operations	(2,310,366)	(499,572)	(5,340,366)	(1,172,746)
Other income (expense)
Interest expense, net of interest income	(1,510,076)	(227,879)	(2,897,264)	(649,288)
Other income		105		105
Loss on settlement of debt and account payable			(56,093)
Gain (loss) on change in fair market value of derivative liabilities	363,349	156,892	2,157,443	(34,386)
Total other income (expense)	(1,146,727)	(70,882)	(795,914)	(683,569)
Net Loss	(3,457,093)	(570,454)	(6,136,280)	(1,856,315)
Gain (loss) attributable to non-controlling interest	(257,101)	(14,453)	(269,897)	(5,163)
Net loss attributable to EVIO, Inc.	$ (3,199,992)	$ (556,001)	$ (5,866,383)	$ (1,851,152)
Basic and diluted loss per common share	$ (0.19)	$ (0.06)	$ (0.41)	$ (0.20)
Weighted average common shares outstanding	18,067,853	9,762,199	15,030,353	9,356,613

UNAUDITED CONSOLIDATED STATEME5

UNAUDITED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($)	3 Months Ended		9 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Unaudited Consolidated Statements Of Comprehensive Income
Net loss	$ (3,199,992)	$ (556,001)	$ (5,866,383)	$ (1,851,152)
Other comprehensive income
Foreign currency translation adjustment	(317,132)		(317,132)
Total other comprehensive income	(317,132)		(317,132)
Comprehensive loss	$ (3,517,124)	$ (556,001)	$ (6,183,515)	$ (1,851,152)

UNAUDITED CONSOLIDATED STATEME6

UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Cash flows from operating activities
Net loss	$ (6,136,280)	$ (1,856,315)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock based compensation	1,644,386	358,794
Common stock issued for services	450,016
Loss on settlement of debt	52,343
Loss on settlement of account payable	3,750
(Gain) loss on derivative liability	(2,157,443)	34,386
Amortization of debt discount	2,561,024	549,581
Depreciation and amortization expense	421,550	189,761
Bad debt expense	53,454
Reduction of security deposit for rent expense		2,095
Changes in operating assets and liabilities:
Accounts receivable	(54,989)	(114,643)
Prepaid expenses	165,787	28,858
Other current asset	(71,400)	40,000
Security deposit	(467,614)	(75,186)
Accounts payable and accrued liabilities	(323,907)	274,051
Interest payable	323,165	84,359
Deferred revenue	(15,300)
Deposits, related party	(180,000)
Customer deposits	(2,013)	55,127
Net cash used in operating activities	(3,733,471)	(429,132)
Cash flows from investing activities
Net cash paid in acquisitions of subsidiaries	(1,574,541)	(6,930)
Purchase of equipment	(883,512)	(48,726)
Net cash used in investing activities	(2,438,053)	(55,656)
Cash flows from financing activities
Repayments of capital leases	(58,103)	(10,152)
Proceeds from issuance of convertible debenture	6,136,120
Proceeds from exercise of common stock warrants	7,999
Proceeds from issuance of common stock	2,041,501	70,000
Proceeds from the issuance of series D preferred stock		114,500
Proceeds from convertible notes, net of original issue discounts and fees	250,000	640,000
Payment on loan payable	(612,531)	(56,396)
Proceeds from notes payable - related party		80,100
Payments on notes payable - related party	(246,526)	(260,767)
Net cash provided by financing activities	7,518,460	577,285
Effect of foreign currency translation adjustment	(193,506)
Net cash increase for period	1,133,430	92,497
Cash balance, beginning of period	121,013	57,486
Cash balance, end of period	1,254,443	149,983
Supplemental disclosure of cash flow information:
Cash paid for interest	171,722	15,348
Cash paid for income tax
Supplemental disclosure of non-cash investing and financing activities
Conversion of convertible note and accrued interest into common stock	2,272,373	501,292
Reclassification of derivative liability to additional paid in capital	2,342,112	1,188,126
Settlement of account payable for common stock	18,750
Common stock issued for settlement of note payable	162,000
Common stock issued for settlement of related party note payable	62,500
Conversion of Series D Preferred stock to common stock	70
Debt discount recorded on convertible notes and convertible debentures payable upon initial measurement of derivative liability	5,784,175	641,637
Debt discounts recorded for original issue discounts on convertible debentures	472,480
Vehicles financed through notes payable		75,165
Equipment financed through capital leases	385,208	105,120
Conversion of Series A Preferred stock to common stock		4,388
Acquisition of C3 Labs through the issuance of note payable and convertible note payable	600,000
Acquisition of Leaf Detective through issuance of convertible note payable	500,000
Acquisition of GreenStyle Consulting assets through issuance of preferred shares, cash and note payable		260,000
Acquisition of GreenHaus through issuance of preferred shares and note payable		$ 800,000

NATURE OF ACTIVITIES AND CONTIN

NATURE OF ACTIVITIES AND CONTINUANCE OF BUSINESS	9 Months Ended
	Jun. 30, 2018
Notes to Financial Statements
NOTE 1 - NATURE OF ACTIVITIES AND CONTINUANCE OF BUSINESS	EVIO, Inc., a Colorado corporation and its subsidiaries (“the Company”) provide analytical testing and advisory services to the emerging legalized cannabis industry. On August 29, 2014, Signal Bay Research completed a reverse merger with a shell company, Quantech Electronics, and in September 2014, changed its name and assumed its operations as Signal Bay. As a part of and prior to the consummation of the reverse merger, William Waldrop and Lori Glauser, principals of Signal Bay Research, Inc., purchased 80% of the issued and outstanding common stock from WB Partners. The merger between the Company and Signal Bay Research was finalized and closed contemporaneously with the share purchase. As part of this share purchase, Mr. Waldrop and Ms. Glauser became the officers and directors of the Company. In September 2014, the Company changed its name to Signal Bay, Inc. and then to EVIO, INC. in September 2017. EVIO, Inc. has selected September 30 as its fiscal year end. The Company is domiciled in the State of Colorado, and its corporate headquarters are located in Bend, Oregon. Signal Bay Services was formed on January 25, 2015, as the management services division of EVIO. On September 17, 2015, the Company entered into a share exchange agreement with CR Labs, Inc., an Oregon Corporation, pursuant to which the Company acquired 80% of the outstanding common stock of CR Labs, Inc. EVIO Labs OR Inc. was formed on April 4, 2016 to become the holding company for all laboratory operations in Oregon. EVIO Labs Eugene, LLC was formed on May 23, 2016, as a wholly owned subsidiary of EVIO Inc. Subsequently on May 24, 2016, EVIO Labs Eugene acquired all of the assets of Oregon Analytical Services, LLC, inclusive of client lists, equipment, trade names and personnel. On June 1, 2016, the Company entered into a share purchase agreement to purchase 80% of the outstanding common stock of Smith Scientific Industries, Inc. d/b/a Kenevir Research in Medford, OR. On October 19, 2016, the Company entered into a Membership Interest Purchase Agreement to purchase 100% of the ownership of GreenHaus Analytical Labs, LLC (“GreenHaus”). GreenHaus is a full-service cannabis testing laboratory. On October 26, 2016, the Company entered in to an Asset Purchase Agreement with Green Style Consulting, LLC which was closed on November 1, 2016 (“GreenStyle”). GreenStyle is a full-service cannabis testing laboratory. The Company entered in to a Membership Interest Purchase Agreement with Viridis Analytics MA, LLC (“Viridis”) which was closed on August 1, 2017. Viridis is a full-service cannabis testing laboratory. On December 29, 2017, the Company entered in to a Membership Purchase Agreement to purchase 60% of the outstanding interests of C3 Labs, LLC which was closed on January 1, 2018 (“C3”). C3 is a full-service cannabis testing laboratory. See Note 10 – Acquisitions On April 29, 2018, the Company entered in to an Asset Purchase Agreement with Leaf Detective, LLC (“Leaf Detective”) to purchase all of the assets of Leaf Detective which was closed on the same date. Leaf Detective is a full-service cannabis testing laboratory. See Note 10 – Acquisitions On May 2, 2018, the Company entered in to a Stock Purchase Agreement with Keystone Labs, Inc. (“Keystone”) to purchase 50% of the outstanding interests of Keystone which was closed on the same date. Keystone is a full-service cannabis testing laboratory operating in Canada. See Note 10 – Acquisitions Going Concern The Company’s financial statements are prepared using accounting principles generally accepted in the United States of America applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. However, the Company has negative working capital, recurring losses, and does not have an established source of revenues sufficient to cover its operating costs. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plan described in the preceding paragraph and eventually attain profitable operations. The accompanying financial statements do not include any adjustments that may be necessary if the Company is unable to continue as a going concern. In the coming year, the Company’s foreseeable cash requirements will relate to continual development of the operations of its business, maintaining its good standing and making the requisite filings with the Securities and Exchange Commission, and the payment of expenses associated with operations and business developments. The Company may experience a cash shortfall and be required to raise additional capital. Historically, it has mostly relied upon internally generated funds such as shareholder loans and advances to finance its operations and growth. Management may raise additional capital by retaining net earnings or through future public or private offerings of the Company’s stock or through loans from private investors, although there can be no assurance that it will be able to obtain such financing. The Company’s failure to do so could have a material and adverse effect upon it and its shareholders.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Jun. 30, 2018
Notes to Financial Statements
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	Basis of Presentation The accompanying unaudited interim consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission, and should be read in conjunction with the audited consolidated financial statements and notes thereto contained in the Company’s most recent Annual Financial Statements filed with the SEC on Form 10-K. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim period presented have been reflected herein. The results of operations for the interim period are not necessarily indicative of the results to be expected for the full year. Notes to the financial statements which would substantially duplicate the disclosures contained in the audited consolidated financial statements for the most recent fiscal period, as reported in the Form 10-K, have been omitted. Foreign Currency Translation The functional currency of the Company’s subsidiary in Canada is the Canadian Dollar. The subsidiary’s assets and liabilities have been translated to U.S. Dollars using the exchange rates in effect at the balance sheet dates. Statements of operations amounts have been translated using the average exchange rate for each period. Resulting gains or losses from translating foreign currency financial statements are recorded as other comprehensive income (loss). Financial Instruments Level 1 - applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities. Level 2 - applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data. Level 3 - applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities. The Company’s financial instruments consist principally of cash, accounts payable, and accrued liabilities. Pursuant to ASC 820 and 825, the fair value of cash is determined based on “Level 1” inputs, which consist of quoted prices in active markets for identical assets. The recorded values of all other financial instruments approximate their current fair values because of their nature and respective maturity dates or durations. The following table sets forth by level with the fair value hierarchy the Company’s financial assets and liabilities measured at fair value on June 30, 2018: Level 1 Level 2 Level 3 Total Liabilities Derivative financial instruments $ - $ - $ 1,579,258 $ 1,579,258 The following table sets forth by level with the fair value hierarchy the Company’s financial assets and liabilities measured at fair value on September 30, 2017: Level 1 Level 2 Level 3 Total Liabilities Derivative financial instruments $ - $ - $ 294,637 $ 294,637 Recently Issued Accounting Pronouncements In January 2017, the FASB issued ASU 2017-04, “ Intangibles—Goodwill and Other (Topic 350), Simplifying the Test for Goodwill Impairment”. In January 2017, the FASB issued ASU 2017-01, “ Business Combinations (Topic 805): Clarifying the Definition of a Business, In April 2016, the FASB issued ASU 2016-10, “Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing” (“ASU 2016-1O”). The amendments in this update clarify the following two aspects to Topic 606: identifying performance obligations and the licensing implementation guidance, while retaining the related principles for those areas. The entity first identifies the promised goods or services in the contract and reduces the cost and complexity. An entity evaluates whether promised goods and services are distinct. Topic 606 includes implementation guidance on determining whether an entity’s promise to grant a license provides a customer with either a right to use the entity’s intellectual property (which is satisfied at a point in time) or a right to access the entity’s intellectual property (which is satisfied over time). The Company evaluated the impacts of ASU 2016-10 and does not believe it will an impact on the Company’s revenue recognition practices and will adopt the standard on October 1, 2018. Other accounting standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on our financial statements upon adoption Net Income (Loss) Per Share Basic loss per share is computed by dividing net income, or loss, by the weighted average number of shares of common stock outstanding for the period. Diluted earnings (loss) per share is computed by dividing net income, or loss, by the weighted average number of shares of common stock outstanding for the period. There were 13,666,226 and 10,071,182 potentially dilutive common shares outstanding as of June 30, 2018 and 2017, respectively. Because of the net losses incurred during the three and nine months ended June 30, 2018 and 2017, the impacts of dilutive instruments would have been anti-dilutive for the period presented and have been excluded from the diluted loss per share calculations. Capital Leases The Company accounts for capital leases in accordance with ACS 840-30. During the year ended September 30, 2017, the Company entered into three separate long-term leases for equipment that contain a $1 buyout option upon lease termination. The Company determined these were capital leases based on the minimum buy out price and capitalized the net present value of the leases which totaled $116,800 as equipment. On February 2, 2018, the Company entered into a long term lease for equipment that contain a bargain purchase option upon lease termination. The Company determined this was a capital lease based on the minimum buy out price and capitalized the net present value of the lease of $385,208 plus the required up front cash payment of $39,986 which totaled $425,194 as equipment. As of September 30, 2017, there was a total of $111,501 of future payments due through December 2019 of which $20,734 are financing charges leaving a total principal balance of $90,967 as of September 30, 2017. Of this amount, $37,990 was current and $52,777 was long term as of September 30, 2017. As of June 30, 2018, there was a total of $470,175 of future payments due through March 2021 of which $39,754 are financing charges leaving a total principal balance of $430,421 as of June 30, 2018. Of this amount, $153,555 was current and $276,866 was long term as of June 30, 2018. Future annual payments required under the capital leases through termination are as follows: Year ended September 30, Principal Interest Total 2018 $ 37,022 $ 7,463 $ 44,485 2019 152,912 20,569 173,481 2020 122,850 9,379 132,229 2021 117,637 2,343 119,980 Total $ 430,421 $ 39,754 $ 470,175 Concentration of Credit Risk Instruments that potentially subject the Company to concentration of credit risk consist principally of cash deposits, notes receivable and accounts receivable. As of June 30, 2018 and September 30, 2017, the Company held $815,877 and $0 of cash at one financial institution in excess of the amount insured by the Federal Deposit Insurance Corporation (“FDIC”) of up to $250,000. As of June 30, 2018 and September 30, 2017, the Company had a note receivable totaling $1,300,000 and $1,300,000 due from a single entity. As of September 30, 2017, the Company had total accounts receivable net of allowances of $229,564. Three separate clients comprised a total of 41% of this balance as follows: Balance Percent of Total Customer 1 $ 42,878 14 % Customer 2 45,635 15 % Customer 3 37,540 12 % All others 178,294 59 % Total 304,347 100 % Allowance for doubtful accounts (74,783 ) Net accounts receivable $ 229,564 As of June 30, 2018 the Company had total accounts receivable net of allowances of $300,215. Two separate clients comprised a total of 21% of this balance as follows: Balance Percent of Total Customer 1 $ 45,635 11 % Customer 2 42,921 10 % All others 339,896 79 % Total 428,452 100 % Allowance for doubtful accounts (128,237 ) Net accounts receivable $ 300,215 Property and Equipment Property and equipment are carried at cost. Expenditures for maintenance and repairs are expensed in the period incurred. Renewals and betterments that materially extend the life of the assets are capitalized. When assets are retired or otherwise disposed of, the cost and related accumulated depreciation are removed from the accounts, and any resulting gain or loss is reflected in income for the period. Depreciation is computed for financial statement purposes on a straight-line basis over estimated useful lives of the related assets and the modified accelerated cost recovery system for federal income tax purposes. The estimated useful lives of depreciable assets are: Estimated Useful Lives Laboratory and Computer Equipment 5 years Furniture and Fixtures 7 years Software 3 years Domains 15 years The Company’s property and equipment consisted of the following as of June 30, 2018 and September 30, 2017: June 30, 2018 September 30, 2017 Furniture and Equipment $ 182,062 $ 146,870 Laboratory Equipment 1,859,567 439,071 Software 63,913 58,333 Leasehold Improvements 139,401 41,081 Vehicles 83,915 75,165 Total 2,328,858 760,520 Accumulated depreciation (457,629 ) (213,447 ) Net value $ 1,871,229 $ 547,073 During the nine months ended June 30, 2018, the Company capitalized a total of $425,194 of equipment purchased through capital leases. There was depreciation expense of $30,705 and $14,001 and $63,796 and $22,135 recorded on equipment purchased through capital leases during the three and nine months ended June 30, 2018 and 2017, respectively.

INTANGIBLE ASSETS

INTANGIBLE ASSETS	9 Months Ended
	Jun. 30, 2018
Notes to Financial Statements
NOTE 3 - INTANGIBLE ASSETS	The Company’s intangible assets consist of customer lists, testing licenses, favorable leases and websites. The components of intangible assets as of June 30, 2018 and September 30, 2017 consist of: June 30, 2018 September 30, 2017 Customer list $ 1,102,462 $ 480,670 License 503,000 256,000 Favorable lease 3,100 3,100 Websites 49,574 41,965 Patent 10,278 - Intellectual property 327,180 - Non-compete agreements 183,111 - Total 2,178,705 781,735 Accumulated amortization (369,828 ) (189,475 ) Net value $ 1,808,877 $ 592,260 The Company estimates amortization to be recorded on existing intangible assets through the estimated lives to be: For the years ended September 30, Amortization 2018 $ 102,585 2019 410,339 2020 387,513 2021 316,214 2022 218,460 Thereafter 373,766 Total $ 1,808,877

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	9 Months Ended
	Jun. 30, 2018
Notes to Financial Statements
NOTE 4 - RELATED PARTY TRANSACTIONS	Through September 30, 2017, the Company received loans from its Chief Operating Officer totaling $106,000 and made repayments totaling $21,795 leaving a balance due as of September 30, 2017 of $84,205. Additionally, the Company made repayments totaling $84,205 during the nine months ended June 30, 2018. The advances are non-interest bearing and due on demand. There was $0 and $84,205 due as of June 30, 2018 and September 30, 2017, and is included in the accompanying consolidated balance sheets as a current portion of notes payable to related parties. During the nine and three months ended June 30, 2018 and 2017, the Company incurred total expenses of $100,000 and $7,858 and $114,317 and $35,530, respectively, for management consulting services performed by Newport Commercial Advisors, an entity fully owned and controlled by our Chief Executive Officer. There was not a balance payable to Newport Commercial Advisors as of June 30, 2018 or September 30, 2017. During the year ended September 30, 2017, the Company received loans from its Chief Executive Officer totaling $80,100 and made repayments totaling $75,650. Additionally, the Company made repayments totaling $4,450 during the nine months ended June 30, 2018. The loans are non-interest bearing and due on demand. There was $0 and $4,450 due as of June 30, 2018 and September 30, 2017. During the year ended September 30, 2017 the Company made repayments to Eric Ezrine, a shareholder of CR Labs, on an outstanding note payable totaling $13,139. The loans carry an interest rate of 0% per annum. There was $130 and $130 due as of June 30, 2018 and September 30, 2017. Additionally, the Company entered into a severance agreement with Mr. Ezrine whereby it agreed to make payments totaling $44,500 through August 2018. The Company made repayments of $22,050 during the year ended September 30, 2017 and $20,000 during the nine months ended June 30, 2018. There was $2,450 and $22,450 accrued as of June 30, 2018 and September 30, 2017, respectively. On May 24, 2016, the Company executed an asset purchase agreement with Sara Lausmann, managing member owner of Oregon Analytical Services, LLC, for $972,500. The terms of the purchase required the issuance of 200,000 shares of Series C Preferred Stock, valued at $80,000, $72,500 in a short-term loan and $700,000 in a long-term note. Through the year ended September 30, 2017, the Company repaid a total of $82,630 to Sara Lausmann, Vice President Client Services. The Company made additional repayments of $79,500 during the nine months ended June 30, 2018. The total amount outstanding is $610,370 and $689,870 as of June 30, 2018 and September 30, 2017, respectively. As of June 30, 2018 and September 30, 2017, $74,370 and $89,870 and $536,000 and $600,000 are included in the accompanying consolidated balance sheets as current and long-term portions of notes payable to related party, respectively. The notes carry interest at a rate of 5% per annum and had accrued interest totaling $71,830 and $47,409 due as of June 30, 2018 and September 30, 2017, respectively. On June 1, 2016, the Company executed a share purchase agreement with Anthony Smith, for the purchase of 80% of Smith Scientific Industries for $636,000. The terms of the purchase required the issuance of 300,000 shares of Series C Preferred Stock, valued at $135,000 and $336,000 in a promissory note. During the year ended September 30, 2017, the Company repaid $50,000 to Anthony Smith, our Chief Science Officer. During the nine months ended June 30, 2018, the Company made repayments totaling $25,000. The note carries interest at a rate of 5% per annum. There was $236,000 and $261,000 of principal due as of June 30, 2018 and September 30, 2017 and $27,986 and $18,846 of accrued interest due as of June 30, 2018 and September 30, 2017, respectively. On October 19, 2016, the Company assumed a $194,512 payable due to Henry Grimmett, a former officer of Greenhaus and former Director of the Company, with its acquisition of Greenhaus Analytical Services, LLC. The note bears interest at 0% per annum and requires repayments of $25,000 quarterly. During the year ended September 30, 2017, the Company made repayments totaling $25,100. Additionally, during the nine months ended June 30, 2018, the Company made cash repayments of $2,000 and agreed to issue 125,000 shares of common stock valued at $62,500 for the settlement of $50,000 of principal resulting in a loss on the settlement of debt of $15,000. There was a total of $117,412 and $169,412 due as of June 30, 2018 and September 30, 2017 of which $50,000 is current and $67,412 is long term. Mr. Grimmett retired and resigned from the board of directors in June 2018. On October 19, 2016, the Company entered into a $340,000 note payable as part of its acquisition of Greenhaus Analytical Services, LLC. At the time of issuance, the note carried a debt discount of $55,277. The note carries interest at a rate of 6% per annum and matures on October 16, 2020. On April 16, 2018, 25% of the outstanding principal balance, or $85,000, became convertible to common stock of the Company at the holder’s option at a rate equal to 80% of the lowest close price in the prior five trading days. The Company recorded an additional debt discount related to the fair value of the embedded conversion feature totaling $29,044. From April 16, 2018 to June 30, 2018, the Company amortized $2,384 of this to interest expense. There was $340,000 and $340,000 of total principal, of which $85,000 and $0, was convertible as of June 30, 2018 and September 30, 2017, respectively. Additionally, there was a total unamortized debt discount of $58,375 and $42,044, of which $26,660 and $0 was related to the convertible portion of the note principal, and $34,764 and $19,506 of accrued interest due as of June 30, 2018 and September 30, 2017, respectively. On November 1, 2016, the Company entered into a $50,000 note payable, that contained a premium of $7,416 based on fair value, to Green Style Consulting, LLC. The Green Style Consulting, LLC Managing Member is our General Manager Northern California, who was hired by the Company concurrent to the asset purchase. The note carries interest at a rate of 5% per annum and matures on October 31, 2018. During the nine months ended June 30, 2018 and the year ended September 30, 2017, the Company made repayments of $24,328 and $6,090. There was $19,582 and $43,910 of principal, $1,250 and $4,028 of unamortized note premium and $705 and $2,055 of accrued interest due as of June 30, 2018 and September 30, 2017, respectively. On May 2, 2018, the Company assumed an outstanding related party loan payable as part of its acquisition of Keystone Labs, Inc (see Note 10 – Acquisitions On October 19, 2016, the Company entered into an asset purchase agreement with Green Style Consulting LLC requiring a future share of net profits generated by Green Style Consulting. The fair value of these future net profits were estimated to be $15,809. There have been no monthly net profits to distribute from the time of acquisition to June 30, 2018 and as such no repayments have been made. There was $15,809 accrued and included in accounts payable and accrued liabilities for future payments related to this earn out as of June 30, 2018 and September 30, 2017. Through September 30, 2016, the Company borrowed a total of $16,200 from our Chief Science Officer to fund operations. The loans are non-interest bearing, due on demand and as such are included in current liabilities. During the year ended September 30, 2017 and the nine months ended June 30, 2018, the Company made repayments totaling $7,000 and $9,200, respectively. There was $0 and $9,200 due as of June 30, 2018 and September 30, 2017, respectively. On March 5, 2018, the Company entered into an agreement with a related party to develop and, in turn, license software. As part of the agreement, the Company advanced the related party $200,000 and entered into a convertible note receivable to secure the advance as collateral. Upon default, the convertible note is due on March 5, 2021, carries interest at a rate of 8% and is convertible to common stock of the issuer at the Company’s discretion at $0.03 per share. As of June 30, 218, the Company determined do not pursue the development of the software and the related party agreed it would return the $200,000. During the nine months ended June 30, 2018, the related party made returned $20,000 leaving $180,000 outstanding as of June 30, 2018. The Company recorded the $180,000 as a deposit with related parties on the accompanying balance sheet.

STOCKHOLDERS' EQUITY

STOCKHOLDERS' EQUITY	9 Months Ended
	Jun. 30, 2018
Notes to Financial Statements
NOTE 5 - STOCKHOLDERS' EQUITY	Series A Convertible Preferred Stock The Company designated 1,850,000 shares of Series A Convertible Preferred Stock (“Series A Preferred Stock”) with a par value of $0.0001 per share. The Company has 0 shares of Series A Convertible Stock issued and outstanding as of June 30, 2018 and September 30, 2017. Series B Convertible Preferred Stock The Company designated 5,000,000 shares of Series B Convertible Preferred Stock (“Series B Preferred Stock”) with a par value of $0.0001 per share. The Company has 5,000,000 shares of Series B Convertible Stock issued and outstanding as of June 30, 2018 and September 30, 2017. Series C Convertible Preferred Stock The Company designated 500,000 shares of Series C Convertible Preferred Stock (“Series C Preferred Stock”) with a par value of $0.0001 per share. There were 500,000 shares of Series C Convertible Stock issued and outstanding as of June 30, 2018 and September 30, 2017. Series D Convertible Preferred Stock The Company designated 1,000,000 shares of Series D Convertible Preferred Stock (“Series D Preferred Stock”) with a par value of $0.0001 per share. During the nine months ended June 30, 2018, the Company accepted five separate conversion notices from Series D Preferred Stockholders resulting in a total of 700,000 shares of common stock being issued for the conversion of 280,000 shares of Series D Preferred Stock. There were 552,500 and 832,500 shares of Series D Convertible Stock issued and outstanding as June 30, 2018 and September 30, 2017, respectively. Common Stock The Company has authorized to issue up to 1,000,000,000 shares of common stock with a par value of $0.0001 per share. During the nine months ended June 30, 2018, the Company issued 222,750 common shares valued at $265,527 for services; 700,000 common shares for the conversion of 280,000 shares of Series D Preferred Stock; 2,561,392 common shares for cash proceeds of $2,041,501; 197,000 common shares under its employee equity incentive plan under which a total expense of $439,210 was recorded; 37,500 common shares for the settlement of $15,000 of accounts payable; 3,990,883 common shares for the conversion of $2,197,000 of outstanding principal on convertible notes payable; 144,852 for the conversion of $75,373 of convertible accrued interest; 324,000 common shares for the settlement of non-convertible debt and interest totaling $122,157; 125,000 common shares for the settlement of non-convertible related party debt totaling $50,000; 13,333 common shares for the exercise of outstanding warrants for which the Company received cash totaling $8,000 and 670,271 common shares valued at $1,414,907 for debt issue costs from a capital raise. All conversions of outstanding principal and accrued interest on convertible notes payable were done so at contractual terms. There were 19,719,903 and 10,732,922 shares of common stock issued and outstanding at June 30, 2018 and September 30, 2017, respectively.

LOANS PAYABLE

LOANS PAYABLE	9 Months Ended
	Jun. 30, 2018
Notes to Financial Statements
NOTE 6 - LOANS PAYABLE	The Company had the following loans payable outstanding as of June 30, 2018 and September 30, 2017: June 30, 2018 September 30, 2017 On March 16, 2017, the Company executed notes payable for the purchase of three vehicles. The notes carry interest at 6.637% annually and mature on March 31, 2023. $ 58,508 $ 71,039 On August 1, 2017, the Company entered into a note payable totaling $500,000 for the acquisition of Viridis (see note 3). The note carries interest at 8% annually and is due on July 1, 2018. 500,000 500,000 On September 6, 2017, the Company entered into a note payable totaling $1,000,000 for the purchase of an outstanding note receivable. The note carries interest at 8% annually and is due on July 6, 2018. 500,000 1,000,000 On August 31, 2017, the Company executed a note payable for $120,000 of which $20,000 was an original issue discount resulting in cash proceeds of $100,000. The note carries interest at 8% annually and is due on March 3, 2018. - 120,000 1,058,508 1,691,039 Less: unamortized original issue discounts (74 ) (127,662 ) Total loans payable 1,058,434 1,563,377 Less: current portion of loans payable 1,011,986 1,503,545 Long-term portion of loans payable $ 46,448 $ 59,832 As discussed in Note 10 – Acquisitions As of June 30, 2018 and September 30, 2017, the Company accrued interest of $59,760 and $12,625, respectively.

CONVERTIBLE NOTES PAYABLE

CONVERTIBLE NOTES PAYABLE	9 Months Ended
	Jun. 30, 2018
Notes to Financial Statements
NOTE 7 - CONVERTIBLE NOTES PAYABLE	The Company has entered into convertible notes payable that convert to common stock of the Company at variable conversion prices. As further discussed in Note 9 – Derivative Liability The following table summarizes all convertible notes outstanding as of September 30, 2017: Holder Issue Date Due Date Principal Unamortized Debt Discount Carrying Value Accrued Interest Noteholder 1 3/2/2017 3/2/2018 $ 125,000 $ (38,112 ) $ 86,888 $ 5,671 Noteholder 1 7/14/2017 7/14/2018 275,600 (11,795 ) 263,805 4,712 Noteholder 1 8/14/2017 8/14/2018 275,600 (13,068 ) 262,532 2,839 Noteholder 4 3/2/2017 3/2/2018 69,000 (50,009 ) 18,991 7,187 Noteholder 4 6/5/2017 3/2/2018 125,000 (70,833 ) 54,167 3,205 Noteholder 4 7/14/2017 7/14/2018 275,600 (11,795 ) 263,805 4,470 Noteholder 4 8/14/2017 8/14/2018 275,600 (13,068 ) 262,532 2,597 $ 1,421,400 $ (208,680 ) $ 1,212,720 $ 30,681 The following table summarizes all convertible notes outstanding as of June 30, 2018: Holder Issue Date Due Date Principal Unamortized Debt Discount Carrying Value Accrued Interest Noteholder 6 4/24/2018 4/24/2019 $ 500,000 $ - $ 500,000 - Noteholder 1 On March 2, 2017, the Company sold and issued a Convertible Promissory Note to an unrelated party, for the principal amount of $125,000 resulting in cash proceeds to the Company of $125,000 pursuant to the terms of a Securities Purchase Agreement of even date therewith. The Note, together with accrued interest at the annual rate of 8%, is due on March 2, 2018. The Note is convertible into the Company’s common stock commencing 180 days from the date of issuance at a conversion price equal to 65% of the lowest trade price of the Company’s common stock for the twenty prior trading days including the date of conversion. During the nine months ended June 30, 2018, the holder elected to convert a total of $125,000 of principal in exchange for 325,562 common shares. There was $0 and $125,000 of principal and $0 and $7,397 of accrued interest due at June 30, 2018 and September 30, 2017, respectively. On July 14, 2017, the Company sold and issued a Convertible Promissory Note to an unrelated party, for the principal amount of $275,600 of which $15,600 was an original issue discount and $10,000 was paid directly to third parties resulting in cash proceeds to the Company of $250,000 pursuant to the terms of a Securities Purchase Agreement of even date therewith. The Note, together with accrued interest at the annual rate of 8%, is due on July 14, 2018. The Note is convertible into the Company’s common stock commencing 180 days from the date of issuance at a conversion price equal to 75% of the lowest trade price of the Company’s common stock for the fifteen prior trading days including the date of conversion. During the nine months ended June 30, 2018, the holder elected to convert $275,600 of outstanding principal and $12,354 of accrued interest to 651,836 and 27,976 shares of common stock. There was $0 and $275,600 of principal and $0 and $4,712 of accrued interest due at June 30, 2018 and September 30, 2017, respectively. On August 14, 2017, the Company sold and issued a Convertible Promissory Note to an unrelated party, for the principal amount of $275,600 of which $15,600 was an original issue discount and $10,000 was paid directly to third parties resulting in cash proceeds to the Company of $250,000 pursuant to the terms of a Securities Purchase Agreement of even date therewith. The Note, together with accrued interest at the annual rate of 8%, is due on August 14, 2018. The Note is convertible into the Company’s common stock commencing 180 days from the date of issuance at a conversion price equal to 75% of the lowest trade price of the Company’s common stock for the fifteen prior trading days including the date of conversion. During the nine months ended June 30, 2018, the holder elected to convert $275,600 of outstanding principal and $15,464 of accrued interest to 403,809 and 22,658 shares of common stock. There was $0 and $275,600 of principal and $0 and $2,839 of accrued interest due at June 30, 2018 and September 30, 2017, respectively. Noteholder 4 On July 14, 2017, the Company sold and issued a Convertible Promissory Note to an unrelated party, for the principal amount of $275,600 of which $15,600 was an original issue discount and $10,000 was paid directly to third parties resulting in cash proceeds to the Company of $250,000 pursuant to the terms of a Securities Purchase Agreement of even date therewith. The Note was funded to the Company on May 3, 2018. The Note, together with accrued interest at the annual rate of 8%, is due on July 14, 2018. The Note is convertible into the Company’s common stock upon funding at a conversion price equal to 75% of the lowest trade price of the Company’s common stock for the fifteen prior trading days including the date of conversion. The Noteholder elected to convert all outstanding principal on the date the note was funded, or May 3, 2018. There was $0 of principal and $0 of accrued interest due at June 30, 2018 and September 30, 2017 respectively. Noteholder 5 On January 1, 2018, the Company entered into a convertible note payable totaling $500,000 in exchange for a 60% interest in C3 Labs, LLC. The note bears no interest, matures on June 30, 2018 and automatically converted to common stock at $0.75 per share on the maturity date. In the event the average trading price of the Company’s common stock during the five days prior to maturity is less than $0.75 per share, the Company was to pay the noteholder the difference between $0.75 and the average trading price during the preceding five days per share converted in cash. On June 30, 2018, the Company issued 666,667 shares of common stock for the conversion of $500,000 of outstanding principal. There was $0 and $0 of principal due as of June 30, 2018 and September 30, 2017, respectively. Noteholder 6 On April 24, 2018, the Company entered into a convertible note payable totaling $500,000 in exchange for 100% of the assets of Leaf Detective LLC. The note bears no interest, matures on April 24, 2019 and automatically converted to common stock at $1.25 per share on the maturity date. In the event the average lowest trading price of the Company’s common stock during the five days prior to maturity is less than $1.25 per share, the Company will pay the noteholder the difference between $1.25 and the average lowest trading price during the preceding five days per share converted in cash. There was $500,000 and $0 of principal due as of June 30, 2018 and September 30, 2017, respectively.

CONVERTIBLE DEBENTURES

CONVERTIBLE DEBENTURES	9 Months Ended
	Jun. 30, 2018
Notes to Financial Statements
NOTE 8 - CONVERTIBLE DEBENTURES	On January 29, 2018, the Company issued a total of 5,973 units of 8% unsecured convertible debentures. Each unit consists of one convertible debenture with a principal face value of $1,000 and 250 warrants. The gross proceeds were $5,973,000. Each warrant entitles the holder thereof to purchase one additional common share of the Company at an exercise price of $0.80 per warrant for a period of 24 months. The convertible debentures have a maturity date of 36 months from issuance. Simple interest will be paid at a rate of 8% per annum in arrears until maturity or until conversion. The principal amount of the debentures and any accrued interest thereon are convertible at the option of the holder into common shares of the Company at any time at a conversion price of $0.60 per share. In addition to the warrants associated with the convertible debentures, the Company issued an additional 597,300 warrants to purchase common stock of the Company as offering costs representing an equivalent of 6% of the fully converted debentures. The warrants are exercisable at $0.60 per share for a period of two years. The Company also issued three separate debentures under the same terms for additional cash proceeds of $610,000. The additional debentures carry an additional 152,500 warrants to purchase additional common shares of the Company at $0.80 per share. Additionally, the outstanding principal and interest may be converted to common stock of the Company at $0.60 per share. Associated with the issuance of the convertible debentures, the Company incurred cash based issuance costs of $702,963, issued common shares valued at $1,414,907 and warrants to purchase additional shares of common stock valued at $1,265,385 for total debt issuance costs of $3,383,255. The debt issuance costs were recorded as a discount to the carrying value of the convertible debentures. The warrants associated with the debt issue costs were valued using a Black-Scholes model with the following assumptions: Expected term of options granted 2.00 years Expected volatility 223 % Risk-free interest rate 2.49 % Expected dividend yield 0 % The Company separately assessed the value of the detachable warrants and conversion features of the convertible debentures. The Company separately initially valued the detachable warrants issued with the convertible debentures at $3,351,160 using a Black-Scholes model with the following assumptions: Expected term of options granted 2.00 years Expected volatility 211-223 % Risk-free interest rate 2.09-2.25 % Expected dividend yield 0 % Additionally, the outstanding principal on convertible debentures totaling $6,583,000 may be converted into common stock of the Company at $0.60 per share for a total of 10,971,667 shares. Due to the variable conversion features of the outstanding convertible notes payable as discussed in Note 7 – Convertible Notes Payable As of June 30, 2018 the Company has amortized $900,471 of the total outstanding debt discount leaving an unamortized debt discount of $5,682,529. The remaining debt discount will be amortized to interest expense over the expected life of the note. There was $6,583,000 of principal and accrued interest totaling $184,287 outstanding as of June 30, 2018.

DERIVATIVE LIABILITY

DERIVATIVE LIABILITY	9 Months Ended
	Jun. 30, 2018
Notes to Financial Statements
NOTE 9 - DERIVATIVE LIABILITY	As of June 30, 2018 and September 30, 2017, Company had a derivative liability balance of $1,579,258 and $294,637 on the balance sheets and recorded a gain of $363,349 and $2,157,443 from derivative liability fair value adjustments during the three and nine months ended June 30, 2018. The derivative liability activity comes from convertible notes payable as follows: On July 14, 2017, the Company issued a $275,600 Convertible Promissory Note to an unrelated party that matured on July 14, 2018. The note bore interest at a rate of 8% per annum and was convertible into the Company’s common shares six months after issuance, at the holder’s option, at the conversion rate equal to a 25% discount from the lowest trading price in the fifteen trading days prior to conversion. The Company analyzed the conversion feature of the agreement for derivative accounting consideration under ASC 815-15 “Derivatives and Hedging” and determined that the embedded conversion features should be classified as a derivative because the exercise price of these convertible notes are subject to a variable conversion rate. In accordance with AC 815, the Company has bifurcated the conversion feature of the note and recorded a derivative liability. The embedded derivative for the note is carried on the Company’s balance sheet at fair value. The derivative liability is marked-to-market each measurement period and any unrealized change in fair value is recorded as a component of the income statement and the associated fair value carrying amount on the balance sheet is adjusted by the change. The Company fair values the embedded derivative using a Monte Carlo Simulation. The aggregate fair value of the derivative at the issuance date of the note was $419,722 which was recorded as a derivative liability on the balance sheet. The Company recorded a debt discount of $260,000 which was up to the face value of the convertible note with the excess fair value at initial measurement of $159,722 being recognized as a loss on derivative fair value measurement. During the nine months ended June 30, 2018, the noteholder elected to convert a total of $275,600 of principal. At June 30, 2018, the Company marked-to-market the fair value of the derivative liabilities related to notes and determined an aggregate fair value of $0 and recorded a $64,148 gain from change in fair value and $355,574 due to conversion for the nine months ended June 30, 2018. The fair value of the embedded derivatives for the notes was determined using a Monte Carlo simulation model based on the following assumptions: (1) expected volatility of 128%, (2) risk-free interest rate of 1.84%, and (3) expected life of 0.22 of a year. On July 14, 2017, the Company issued a $275,600 Convertible Promissory Note to an unrelated party that matured on July 14, 2018. The note bore interest at a rate of 8% per annum and was convertible into the Company’s common shares six months after issuance, at the holder’s option, at the conversion rate equal to a 25% discount from the lowest trading price in the fifteen trading days prior to conversion. The Company analyzed the conversion feature of the agreement for derivative accounting consideration under ASC 815-15 “Derivatives and Hedging” and determined that the embedded conversion features should be classified as a derivative because the exercise price of these convertible notes are subject to a variable conversion rate. In accordance with AC 815, the Company has bifurcated the conversion feature of the note and recorded a derivative liability. The embedded derivative for the note is carried on the Company’s balance sheet at fair value. The derivative liability is marked-to-market each measurement period and any unrealized change in fair value is recorded as a component of the income statement and the associated fair value carrying amount on the balance sheet is adjusted by the change. The Company fair values the embedded derivative a Monte Carlo simulation. The aggregate fair value of the derivative at the issuance date of the note was $419,796 which was recorded as a derivative liability on the balance sheet. The Company recorded a debt discount of $260,000 which was up to the face value of the convertible note with the excess fair value at initial measurement of $159,796 being recognized as a loss on derivative fair value measurement. During the nine months ended June 30, 2018, the noteholder elected to convert a total of $275,600 of principal. At June 30, 2018, the Company marked-to-market the fair value of the derivative liabilities related to notes and determined an aggregate fair value of $0 and recorded a $8,276 gain from change in fair value and $411,520 due to conversion for the nine months ended June 30, 2018. The fair value of the embedded derivatives for the notes was determined using a Monte Carlo simulation model based on the following assumptions: (1) expected volatility of 128%, (2) risk-free interest rate of 1.85%, and (3) expected life of 0.07 of a year. On August 14, 2017, the Company issued a $275,600 Convertible Promissory Note to an unrelated party that matured on August 14, 2018. The note bore interest at a rate of 8% per annum and was convertible into the Company’s common shares six months after issuance, at the holder’s option, at the conversion rate equal to a 25% discount from the lowest trading price in the fifteen trading days prior to conversion. The Company analyzed the conversion feature of the agreement for derivative accounting consideration under ASC 815-15 “Derivatives and Hedging” and determined that the embedded conversion features should be classified as a derivative because the exercise price of these convertible notes are subject to a variable conversion rate. In accordance with AC 815, the Company has bifurcated the conversion feature of the note and recorded a derivative liability. The embedded derivative for the note is carried on the Company’s balance sheet at fair value. The derivative liability is marked-to-market each measurement period and any unrealized change in fair value is recorded as a component of the income statement and the associated fair value carrying amount on the balance sheet is adjusted by the change. The Company fair values the embedded derivative using a Monte Carlo Simulation. The aggregate fair value of the derivative at the issuance date of the note was $330,278 which was recorded as a derivative liability on the balance sheet. The Company recorded a debt discount of $260,000 which was up to the face value of the convertible note with the excess fair value at initial measurement of $70,278 being recognized as a loss on derivative fair value measurement. During the nine months ended June 30, 2018, the noteholder elected to convert a total of $275,600 of principal. At June 30, 2018, the Company marked-to-market the fair value of the derivative liabilities related to notes and determined an aggregate fair value of $0 and recorded a $13,917 gain from change in fair value and $316,361 due to the conversion for the nine months ended June 30, 2018. The fair value of the embedded derivatives for the notes was determined using a Monte Carlo simulation model based on the following assumptions: (1) expected volatility of 128%, (2) risk-free interest rate of 1.81%, and (3) expected life of 0.50 of a year. On August 14, 2017, the Company issued a $275,600 Convertible Promissory Note to an unrelated party that matured on August 14, 2018. The note bore interest at a rate of 8% per annum and was convertible into the Company’s common shares six months after issuance, at the holder’s option, at the conversion rate equal to a 25% discount from the lowest trading price in the fifteen trading days prior to conversion. The Company analyzed the conversion feature of the agreement for derivative accounting consideration under ASC 815-15 “Derivatives and Hedging” and determined that the embedded conversion features should be classified as a derivative because the exercise price of these convertible notes are subject to a variable conversion rate. In accordance with AC 815, the Company has bifurcated the conversion feature of the note and recorded a derivative liability. The embedded derivative for the note is carried on the Company’s balance sheet at fair value. The derivative liability is marked-to-market each measurement period and any unrealized change in fair value is recorded as a component of the income statement and the associated fair value carrying amount on the balance sheet is adjusted by the change. The Company fair values the embedded derivative using a Monte Carlo Simulation. The aggregate fair value of the derivative at the issuance date of the note was $329,356 which was recorded as a derivative liability on the balance sheet. The Company recorded a debt discount of $260,000 which was up to the face value of the convertible note with the excess fair value at initial measurement of $69,356 being recognized as a loss on derivative fair value measurement. During the nine months ended June 30, 2018, the noteholder elected to convert a total of $275,600 of principal. At June 30, 2018, the Company marked-to-market the fair value of the derivative liabilities related to notes and determined an aggregate fair value of $0 and recorded a $177,523 loss from change in fair value and $446,879 due to the conversion for the nine months ended June 30, 2018. The fair value of the embedded derivatives for the notes was determined using a Monte Carlo simulation model based on the following assumptions: (1) expected volatility of 129%, (2) risk-free interest rate of 1.88%, and (3) expected life of 0.29 of a year. On April 16, 2018, $85,000 of $340,000 principal on a note with a related party became convertible to common stock at the option of the noteholder. The note bears interest at a rate of 6% per annum and was convertible into the Company’s common shares six months after issuance, at the holder’s option, at the conversion rate equal to a 20% discount from the lowest trading price in the five trading days prior to conversion. The Company analyzed the conversion feature of the agreement for derivative accounting consideration under ASC 815-15 “Derivatives and Hedging” and determined that the embedded conversion features should be classified as a derivative because the exercise price of these convertible notes are subject to a variable conversion rate. In accordance with AC 815, the Company has bifurcated the conversion feature of the note and recorded a derivative liability. The embedded derivative for the note is carried on the Company’s balance sheet at fair value. The derivative liability is marked-to-market each measurement period and any unrealized change in fair value is recorded as a component of the income statement and the associated fair value carrying amount on the balance sheet is adjusted by the change. The Company fair values the embedded derivative using a Monte Carlo Simulation. The aggregate fair value of the derivative at the issuance date of the note was $29,044 which was recorded as a derivative liability on the balance sheet. The Company recorded a debt discount of $29,044 which was up to the value of the convertible portion of the note. At June 30, 2018, the Company marked-to-market the fair value of the derivative liabilities related to notes and determined an aggregate fair value of $29,217 and recorded a $173 loss from the change in fair value for the nine months ended June 30, 2018. The fair value of the embedded derivatives for the notes was determined using a Monte Carlo simulation model based on the following assumptions: (1) expected volatility of 128%, (2) risk-free interest rate of 2.55%, and (3) expected life of 2.3 years. On July 14, 2017, the Company issued a $275,600 Convertible Promissory Note to an unrelated party that matured on July 14, 2018. The note bore interest at a rate of 8% per annum and was convertible into the Company’s common shares at the date of funding, at the holder’s option, at the conversion rate equal to a 25% discount from the lowest trading price in the fifteen trading days prior to conversion. The note was funded on May 3, 2018 at which point it was immediately convertible. The Company analyzed the conversion feature of the agreement for derivative accounting consideration under ASC 815-15 “Derivatives and Hedging” and determined that the embedded conversion features should be classified as a derivative because the exercise price of these convertible notes are subject to a variable conversion rate. In accordance with AC 815, the Company has bifurcated the conversion feature of the note and recorded a derivative liability. The embedded derivative for the note is carried on the Company’s balance sheet at fair value. The derivative liability is marked-to-market each measurement period and any unrealized change in fair value is recorded as a component of the income statement and the associated fair value carrying amount on the balance sheet is adjusted by the change. The Company fair values the embedded derivative using a Monte Carlo Simulation. The aggregate fair value of the derivative at the issuance date of the note was $404,548 which was recorded as a derivative liability on the balance sheet. The Company recorded a debt discount of $250,000 which was up to the face value of the convertible note with the excess fair value at initial measurement of $154,548 being recognized as a loss on derivative fair value measurement. During the nine months ended June 30, 2018, the noteholder elected to convert a total of $275,600 of principal. At June 30, 2018, the Company marked-to-market the fair value of the derivative liabilities related to notes and determined an aggregate fair value of $0 and recorded a change of $404,548 due to the conversion for the nine months ended June 30, 2018. The fair value of the embedded derivatives for the notes was determined using a Monte Carlo simulation model based on the following assumptions: (1) expected volatility of 129%, (2) risk-free interest rate of 1.86%, and (3) expected life of 0.28 of a year. As discussed in Note 8 – Convertible Debentures The derivative for the warrants is carried on the Company’s balance sheet at fair value. The derivative liability is marked-to-market each measurement period and any unrealized change in fair value is recorded as a component of the income statement and the associated fair value carrying amount on the balance sheet is adjusted by the change. The Company fair values the embedded derivative using the Black-Scholes option pricing model. The aggregate fair value of the derivative at the issuance date of the warrants was $4,616,545 which was recorded as a derivative liability on the balance sheet. The Company recorded a debt discount of $4,465,131 which was up to the face value of the convertible debentures with the excess fair value at initial measurement of $151,414 being recognized as a loss on derivative fair value measurement. At June 30, 2018, the Company marked-to-market the fair value of the derivative liabilities related to warrants and determined an aggregate fair value of $1,550,041 and recorded a $3,054,253 gain from change in fair value and $12,251 change due to warrant exercises for the nine months ended June 30, 2018. The fair value of the embedded derivatives for the notes was determined using a Black-Scholes option pricing model based on the following assumptions: (1) expected volatility of 118% - 129%, (2) risk-free interest rate of 2.52%, (3) exercise prices of $0.60 - $0.80, and (4) expected lives of 1.59 – 1.69 of a year. The following table summarizes the derivative liabilities included in the balance sheet at June 30 2018: Fair Value of Embedded Derivative Liabilities: Balance, September 30, 2017 $ 294,637 Initial measurement of derivative liabilities 6,549,289 Change in fair market value (2,922,558 ) Write off due to conversion (2,342,112 ) Balance, June 30, 2018 $ 1,579,258 The following table summarizes the gain (loss) on derivative liability included in the income statement for the three and nine months ended June 30, 2018 and 2017, respectively. Three Months Ended June 30, Nine Months Ended June 30, 2018 2017 2018 2017 Day one loss due to derivatives on convertible debt $ (154,548 ) $ (69,734 ) $ (765,115 ) $ (421,940 ) Change in fair value of derivatives 517,897 226,626 2,922,558 387,554 Total derivative gain (loss) $ 363,349 $ 156,892 $ 2,157,443 $ (34,386 )

ACQUISITIONS

ACQUISITIONS	9 Months Ended
	Jun. 30, 2018
Notes to Financial Statements
NOTE 10 - ACQUISITIONS	C3 Labs, LLC On January 1, 2018, the Company completed its acquisition of C3 Labs, LLC (“C3 Labs”). In consideration of a 60% ownership, the Company issued a $500,000 convertible note payable which carries no interest and matures on June 30, 2018. Upon maturation, the note will convert to common stock of the Company at $0.75 per share. Additionally, the Company issued a $100,000 note payable due on March 31, 2018 which bears no interest. The Company has been granted two options to purchase additional interest of C3 Labs subject to the following terms and conditions. (a) 30% Option. Effective as of Closing and terminating the date three (3) years from the Closing Date, the C3 Members hereby collectively grant EVIO the right to ratably purchase from the C3 Members an aggregate of 30% of the Interests in C3 LABS following the issuance of 60% of the Interests to EVIO. EVIO may exercise its option by providing C3 LABS and the C3 Members written notice of its intent to exercise the option. The C3 Members shall have three (3) days following the date of such notice to execute assignments of Interests totaling 30% of the then outstanding membership interests in C3 LABS in favor of EVIO California. If EVIO should elect to exercise its option within nine (9) months from the Closing Date, the exercise price for the 30% of Interests shall be $450,000.00, to be paid in cash or EVIO’s common stock, as agreed by the C3 Members. If EVIO does not exercise the option within nine (9) months from the Closing Date, the exercise price shall be set by mutual agreement between the parties or, if no such agreement can be reached, as determined by an independent third-party valuation by an appraiser agreed to by the parties. (b) 10% Option. Effective as of three (3) years after the Closing Date and terminating the date twenty four (24) months therefrom, the C3 Members hereby collectively grant EVIO the right to ratably purchase from the C3 Members an aggregate of 10% of the then outstanding Interests in C3 LABS (comprising the remaining Interests not owned by EVIO). EVIO may exercise its option by providing C3 LABS and the C3 Members written notice of its intent to exercise the option. The C3 Members shall have three (3) days following the date of such notice to execute assignments of Interests totaling 10% of the then outstanding membership interests in C3 LABS in favor of EVIO. Upon notice of its intent to exercise the option granted hereby, the exercise price shall be set by mutual agreement between the parties or, if no such agreement can be reached, as determined by an independent third-party valuation by an appraiser agreed to by the parties. The Company applied the acquisition method to the business combination and valued each of the assets acquired (cash, accounts receivable, security deposits, customer lists, certain testing licenses, equipment and non-compete agreements) and liabilities assumed (accounts payable and deferred rent payable) at fair value as of the acquisition date. The cash, accounts receivable, security deposits, accounts payable and deferred rent payable were deemed to be recorded at fair value as of the acquisition date. The Company determined the fair value of the equipment to be historical net book value. The preliminary allocation of the purchase price was based on estimates of the fair value of the assets and liabilities assumed based on provisional amounts. The allocation of the excess purchase price is not final and the amounts allocated to intangible assets are subject to change pending the completion of final valuations of certain assets and liabilities. Under the purchase agreement, the Company issued a $100,000 promissory note and a $500,000 convertible promissory note for total consideration of $600,000 in exchange for a 60% interest. The following table shows the estimated fair values of the assets acquired and liabilities assumed at the date of acquisition: ASSETS ACQUIRED Cash $ 20,468 Accounts receivable 5,110 Other current assets 3,461 Security deposits 20,000 Equipment 244,875 License 247,000 Customer list 112,000 Non-compete agreement 88,000 Goodwill 291,697 TOTAL ASSETS ACQUIRED $ 1,032,611 LIABILITIES ASSUMED Accounts payable 4,314 Deferred rent 28,297 TOTAL LIABILITIES ASSUMED 32,611 Non-controlling interest (400,000 ) NET ASSETS ACQUIRED $ 600,000 The license and customer list will be amortized over 7 years and non-compete agreement over 5 years From the date of acquisition on January 1, 2018 to June 30, 2018 C3 Labs generated total revenues of $75,835. Keystone Labs, Inc. On May 2, 2018, EVIO Canada, Inc, (“EVIO Canada”), a wholly-owned subsidiary of the Company consummated certain agreements to acquire a 50% interest of Keystone Labs, Inc. (“Keystone”) for $2,495,000 Canadian Dollars in cash. The Company applied the acquisition method to the business combination and valued each of the assets acquired (cash, accounts receivable, prepaid expenses and other current assets, websites, customer lists, certain testing licenses, equipment, non-compete agreements and other intellectual property) and liabilities assumed (accounts payable, capital lease obligations, deferred revenue and related party payables) at fair value as of the acquisition date. The cash, accounts receivable, prepaid expenses and other current assets, accounts payable, related party payables and deferred revenues were deemed to be recorded at fair value as of the acquisition date. The Company determined the fair value of the equipment to be historical net book value. The preliminary allocation of the purchase price was based on estimates of the fair value of the assets and liabilities assumed based on provisional amounts. The allocation of the excess purchase price is not final and the amounts allocated to intangible assets are subject to change pending the completion of final valuations of certain assets and liabilities. Under the purchase agreement, the Company paid a total of $2,495,000 Canadian Dollars which equated to $1,962,095 US Dollars in exchange for a 50% interest. The following table shows the estimated fair values of the assets acquired and liabilities assumed at the date of acquisition: ASSETS ACQUIRED Cash $ 371,278 Accounts receivable 65,815 Prepaid expenses and other current assets 38,415 Equipment 40,774 Intellectual property 334,719 Websites and domain names 18,299 Customer list 521,539 Non-compete agreement 97,302 Goodwill 2,716,027 TOTAL ASSETS ACQUIRED $ 4,204,167 LIABILITIES ASSUMED Accounts payable 108,207 Capital lease obligation 12,826 Related party payables 153,755 Deferred revenue 5,189 TOTAL LIABILITIES ASSUMED 279,977 Non-controlling interest (1,962,095 ) NET ASSETS ACQUIRED $ 1,962,095 The customer list, website and domain names, non-compete agreements and intellectual property will be amortized over 7, 2, 2 and 5 years, respectively. From the date of acquisition on May 2, 2018 to June 30, 2018 Keystone generated total revenues of $73,284. Leaf Detective, LLC On April 29, 2018, EVIO Labs Humbolt, Inc., a wholly-owned subsidiary of the Company entered into an Asset Purchase Agreement (“Agreement”) with Leaf Detective, LLC. (“Leaf Detective”). Pursuant to the Agreement, Leaf Detective agreed to sell its assets including equipment, tools, brand, customer lists, customer contracts, rental agreements, and equipment leases for total consideration of $500,000 in a Convertible Promissory Note (“Note”). The Note is convertible at $1.25 per share, bears no interest and has a maturity of 12 months from the closing of the Agreement. The Company applied the acquisition method to the business combination and valued each of the assets acquired (equipment and lab supplies) at fair value as of the acquisition date. The lab supplies were deemed to be recorded at fair value as of the acquisition date. The Company determined the fair value of the equipment to be historical net book value. The preliminary allocation of the purchase price was based on estimates of the fair value of the assets and liabilities assumed based on provisional amounts. The allocation of the excess purchase price is not final and the amounts allocated to intangible assets are subject to change pending the completion of final valuations of certain assets and liabilities. Under the purchase agreement, the Company issued a $500,000 convertible promissory note in exchange for all assets. The following table shows the estimated fair values of the assets acquired and liabilities assumed at the date of acquisition: ASSETS ACQUIRED Lab supplies $ 7,715 Equipment 14,925 Goodwill 477,900 TOTAL ASSETS ACQUIRED $ 500,000 From the date of acquisition on April 29, 2018 to June 30, 2018 EVIO Humboldt generated total revenues of $7,560.

INDUSTRY SEGMENTS

INDUSTRY SEGMENTS	9 Months Ended
	Jun. 30, 2018
Notes to Financial Statements
NOTE 11 - INDUSTRY SEGMENTS	This summary reflects the Company’s current segments, as described below. Corporate The parent Company provides overall management and corporate reporting functions for the entire organization. Consulting The Company provides advisory, licensing and compliance services to the cannabis industry. Consulting clients are located in states that have state managed medical and/or recreational programs. EVIO assists these companies with license applications, business planning, state compliance and ongoing operational support. Testing Services The Company provides analytical testing services to the cannabis industry under the EVIO Labs brand. As of June 30, 2018, EVIO Labs has nine operating labs. EVIO Labs clients are located in Oregon, California and Massachusetts and consist of growers, processors and dispensaries. Operating under the rules of the appropriate state regulating body, EVIO Labs certifies products have been tested and are free from pesticides and other containments before resale to patients and consumers. Nine months ended June 30, 2018 Corporate Consulting Services Testing Services Total Consolidated Revenue $ - $ 141,453 $ 2,172,061 $ 2,313,514 Segment income (loss) from operations (2,033,171 ) (2,059,269 ) (1,247,926 ) (5,340,366 ) Total assets 1,899,440 372,224 11,497,993 13,769,657 Capital expenditures - (1,038 ) (882,474 ) (883,512 ) Depreciation and amortization - 11,246 410,304 421,550 Nine months ended June 30, 2017 Corporate Consulting Services Testing Services Total Consolidated Revenue $ - $ 196,520 $ 2,081,877 $ 2,278,397 Segment income (loss) from operations (589,258 ) (192,898 ) (390,590 ) (1,172,746 ) Total assets 85,877 240,459 3,644,591 3,970,927 Capital expenditures - (1,038 ) (47,688 ) (48,726 ) Depreciation and amortization - 17,922 171,839 189,761 Three months ended June 30, 2018 Corporate Consulting Services Testing Services Total Consolidated Revenue $ - $ 38,637 $ 595,701 $ 634,338 Segment income (loss) from operations (573,239 ) (1,083,993 ) (653,134 ) (2,310,366 ) Total assets 1,899,440 372,224 11,497,993 13,769,657 Capital expenditures - - (351,998 ) (351,998 ) Depreciation and amortization - 4,075 191,500 195,575 Three months ended June 30, 2017 Corporate Consulting Services Testing Services Total Consolidated Revenue $ - $ 9,345 $ 767,873 $ 777,218 Segment income (loss) from operations (210,554 ) (197,546 ) (91,472 ) (499,572 ) Total assets 85,877 240,459 3,644,591 3,970,927 Capital expenditures - - (2,962 ) (2,962 ) Depreciation and amortization - 5,975 63,056 69,031

STOCK OPTIONS AND WARRANTS

STOCK OPTIONS AND WARRANTS	9 Months Ended
	Jun. 30, 2018
Notes to Financial Statements
NOTE 12 - STOCK OPTIONS AND WARRANTS	The following table summarizes all stock option and warrant activity for the nine months ended June 30, 2018: Shares Weighted- Average Exercise Price Per Share Outstanding, September 30, 2017 655,000 $ 0.902 Granted 4,268,049 0.795 Exercised (13,333 ) 0.600 Forfeited (70,000 ) 0.891 Expired - - Outstanding, June 30, 2018 4,839,716 $ 0.809 The following table discloses information regarding outstanding and exercisable options and warrants at June 30, 2018: Outstanding Exercisable Exercise Prices Number of Option Shares Weighted Average Exercise Price Weighted Average Remaining Life (Years) Number of Option Shares Weighted Average Exercise Price $ 0.400 120,000 $ 0.400 3.13 90,000 $ 0.400 $ 0.500 165,000 $ 0.500 3.20 123,750 $ 0.500 $ 0.600 583,966 $ 0.600 1.58 583,966 $ 0.600 $ 0.650 145,000 $ 0.650 4.32 36,250 $ 0.650 $ 0.800 3,195,750 $ 0.800 3.49 2,420,750 $ 0.800 $ 1.100 170,000 $ 1.100 4.97 42,500 $ 1.100 $ 1.260 230,000 $ 1.260 4.01 57,500 $ 1.260 $ 1.280 150,000 $ 1.280 4.80 18,750 $ 1.280 $ 1.300 10,000 $ 1.300 3.31 5,000 $ 1.300 $ 1.386 60,000 $ 1.386 4.01 15,000 $ 1.386 $ 1.666 10,000 $ 1.666 4.09 2,500 $ 1.666 Total 4,839,716 $ 0.809 3.39 3,398,466 $ 0.761 In determining the compensation cost of the stock options granted, the fair value of each option grant has been estimated on the date of grant using the Black-Scholes option pricing model. The assumptions used in these calculations are summarized as follows: June 30, 2018 Expected term of options granted 4.98 – 5.00 years Expected volatility 251-256 % Risk-free interest rate 2.01–2.25 % Expected dividend yield 0 % The Company recognized stock option expense of $321,898 and $14,133 and $1,389,666 and $63,917 during the three and nine months ended June 30, 2018 and 2017, respectively. There was $1,198,583 of unrecognized stock based compensation expense as of June 30, 2018.

COMMETTMENTS AND CONTINGECIES

COMMETTMENTS AND CONTINGECIES	9 Months Ended
	Jun. 30, 2018
Notes to Financial Statements
NOTE 13 - COMMETTMENTS AND CONTINGECIES	From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business. We are currently not aware of any such legal proceedings or claims that we believe will have, individually or in the aggregate, a material adverse effect on our business, financial condition or operating results. During the year ended September 30, 2017, the Company purchased a software license for $200,000 in cash. The Company relied on the representation of the seller regarding the assignability of the license. However, independent verification of the assignability was not obtained. As a result, the Company recognized a $200,000 impairment loss on the write off of the asset. There have been no additional amounts accrued for potential losses related to the assignability of the license. The Company has entered into various office and laboratory leases as well as a long term operating lease. Future minimum rental payments under the terms of the lease are: Year ending September 30, 2018 168,657 2019 639,375 2020 609,812 2021 417,809 2022 291,974 2023 132,660 Total $ 2,260,290

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	9 Months Ended
	Jun. 30, 2018
Notes to Financial Statements
NOTE 14 - SUBSEQUENT EVENTS	Common Stock Issuances The Company made the following issuances of common stock subsequent to June 30, 2018: · 165,000 common shares valued at $178,250 subject to the vesting requirements of certain agreements with employees. · 5,000 common shares valued at $5,450 for services performed. · 208,332 common shares for the conversion of $125,000 of outstanding principal on convertible debentures. Acquisitions On June 27, 2018, Greenhaus Analytical Labs, LLC (“Greenhaus”), a wholly-owned subsidiary of the Company entered into a Purchase and Sale Agreement (the “PSA”) with Michael G. Myers (“Myers”). Pursuant to the PSA, Greenahus will acquire certain real estate for a total purchase price of $1,150,000, with $25,000 due upon execution of the PSA, $475,000 to be escrowed, and $650,000 in the form of a secured promissory note (the “Myers Note”). The Myers Note will be secured by a deed of trust for the Property and bears 8% interest per annum. The Property purchase is subject to a commercial lease held by MRX (defined below) which will be acquired by Greenhaus pursuant to the APA (below defined). On June 27, 2018, Greenhaus executed an Asset Purchase Agreement (“APA”) with MRX Labs LLC, an Oregon limited liability company (“MRX”) which was closed on July 5, 2018. Pursuant to the APA, Greenhaus acquired certain tangible and intangible assets of MRX, including but limited to (i) furniture, (ii) fixtures, (iii) client and vender contracts, (iv) inventory, (v) goodwill, (vi) ownership rights to any copyrightable works, including all related copyright registrations, (vii) know-how or other trade secrets, whether or not reduced to practice, (viii) licenses, options to license and other contractual rights to use intellectual property, (ix) computer and electronic data processing programs and software programs, (x) equipment, (xi) customer lists, (xii) “know-how “ and proprietary information and trade secrets relating to the MRX’s business operations, (xiii) manufacturers’ warranties (including pending warranty claims) and manuals relating to the purchased assets (xiv) an irrevocable license to use the tradename “MRX Labs” for six months, (xv) certain assets specifically listed in Exhibit A of the APA and (xvi) MRX’s books and records relating to the foregoing (the “Assets”). The total purchase price for the Assets is $1,500,000, payable as a cashier’s check or wire transfer in the amount of $750,000 and a promissory note in the principal amount of $750,000. Debt Issuance On August 1, 2018, the Company issued a promissory note for $330,000 due at the earlier of October 1, 2018 or the closing of a financing or series of financing with gross proceeds of $3,000,000. The note bears interest at 8% per annum and had a $30,000 original issue discount. Default provisions on the note include a conversion feature where the holder can convert the unpaid balance to the Company’s stock at $0.60 per share.

SUMMARY OF SIGNIFICANT ACCOUN21

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Jun. 30, 2018
Summary Of Significant Accounting Policies Policies
Basis of Presentation	The accompanying unaudited interim consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission, and should be read in conjunction with the audited consolidated financial statements and notes thereto contained in the Company’s most recent Annual Financial Statements filed with the SEC on Form 10-K. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim period presented have been reflected herein. The results of operations for the interim period are not necessarily indicative of the results to be expected for the full year. Notes to the financial statements which would substantially duplicate the disclosures contained in the audited consolidated financial statements for the most recent fiscal period, as reported in the Form 10-K, have been omitted.
Foreign Currency Translation	The functional currency of the Company’s subsidiary in Canada is the Canadian Dollar. The subsidiary’s assets and liabilities have been translated to U.S. Dollars using the exchange rates in effect at the balance sheet dates. Statements of operations amounts have been translated using the average exchange rate for each period. Resulting gains or losses from translating foreign currency financial statements are recorded as other comprehensive income (loss).
Financial Instruments	Level 1 - applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities. Level 2 - applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data. Level 3 - applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities. The Company’s financial instruments consist principally of cash, accounts payable, and accrued liabilities. Pursuant to ASC 820 and 825, the fair value of cash is determined based on “Level 1” inputs, which consist of quoted prices in active markets for identical assets. The recorded values of all other financial instruments approximate their current fair values because of their nature and respective maturity dates or durations. The following table sets forth by level with the fair value hierarchy the Company’s financial assets and liabilities measured at fair value on June 30, 2018: Level 1 Level 2 Level 3 Total Liabilities Derivative financial instruments $ - $ - $ 1,579,258 $ 1,579,258 The following table sets forth by level with the fair value hierarchy the Company’s financial assets and liabilities measured at fair value on September 30, 2017: Level 1 Level 2 Level 3 Total Liabilities Derivative financial instruments $ - $ - $ 294,637 $ 294,637
Recently Issued Accounting Pronouncements	In January 2017, the FASB issued ASU 2017-04, “ Intangibles—Goodwill and Other (Topic 350), Simplifying the Test for Goodwill Impairment”. In January 2017, the FASB issued ASU 2017-01, “ Business Combinations (Topic 805): Clarifying the Definition of a Business, In April 2016, the FASB issued ASU 2016-10, “Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing” (“ASU 2016-1O”). The amendments in this update clarify the following two aspects to Topic 606: identifying performance obligations and the licensing implementation guidance, while retaining the related principles for those areas. The entity first identifies the promised goods or services in the contract and reduces the cost and complexity. An entity evaluates whether promised goods and services are distinct. Topic 606 includes implementation guidance on determining whether an entity’s promise to grant a license provides a customer with either a right to use the entity’s intellectual property (which is satisfied at a point in time) or a right to access the entity’s intellectual property (which is satisfied over time). The Company evaluated the impacts of ASU 2016-10 and does not believe it will an impact on the Company’s revenue recognition practices and will adopt the standard on October 1, 2018. Other accounting standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on our financial statements upon adoption
Net Income (Loss) Per Share	Basic loss per share is computed by dividing net income, or loss, by the weighted average number of shares of common stock outstanding for the period. Diluted earnings (loss) per share is computed by dividing net income, or loss, by the weighted average number of shares of common stock outstanding for the period. There were 13,666,226 and 10,071,182 potentially dilutive common shares outstanding as of June 30, 2018 and 2017, respectively. Because of the net losses incurred during the three and nine months ended June 30, 2018 and 2017, the impacts of dilutive instruments would have been anti-dilutive for the period presented and have been excluded from the diluted loss per share calculations.
Capital Leases	The Company accounts for capital leases in accordance with ACS 840-30. During the year ended September 30, 2017, the Company entered into three separate long-term leases for equipment that contain a $1 buyout option upon lease termination. The Company determined these were capital leases based on the minimum buy out price and capitalized the net present value of the leases which totaled $116,800 as equipment. On February 2, 2018, the Company entered into a long term lease for equipment that contain a bargain purchase option upon lease termination. The Company determined this was a capital lease based on the minimum buy out price and capitalized the net present value of the lease of $385,208 plus the required up front cash payment of $39,986 which totaled $425,194 as equipment. As of September 30, 2017, there was a total of $111,501 of future payments due through December 2019 of which $20,734 are financing charges leaving a total principal balance of $90,967 as of September 30, 2017. Of this amount, $37,990 was current and $52,777 was long term as of September 30, 2017. As of June 30, 2018, there was a total of $470,175 of future payments due through March 2021 of which $39,754 are financing charges leaving a total principal balance of $430,421 as of June 30, 2018. Of this amount, $153,555 was current and $276,866 was long term as of June 30, 2018. Future annual payments required under the capital leases through termination are as follows: Year ended September 30, Principal Interest Total 2018 $ 37,022 $ 7,463 $ 44,485 2019 152,912 20,569 173,481 2020 122,850 9,379 132,229 2021 117,637 2,343 119,980 Total $ 430,421 $ 39,754 $ 470,175
Concentration of Credit Risk	Instruments that potentially subject the Company to concentration of credit risk consist principally of cash deposits, notes receivable and accounts receivable. As of June 30, 2018 and September 30, 2017, the Company held $815,877 and $0 of cash at one financial institution in excess of the amount insured by the Federal Deposit Insurance Corporation (“FDIC”) of up to $250,000. As of June 30, 2018 and September 30, 2017, the Company had a note receivable totaling $1,300,000 and $1,300,000 due from a single entity. As of September 30, 2017, the Company had total accounts receivable net of allowances of $229,564. Three separate clients comprised a total of 41% of this balance as follows: Balance Percent of Total Customer 1 $ 42,878 14 % Customer 2 45,635 15 % Customer 3 37,540 12 % All others 178,294 59 % Total 304,347 100 % Allowance for doubtful accounts (74,783 ) Net accounts receivable $ 229,564 As of June 30, 2018 the Company had total accounts receivable net of allowances of $300,215. Two separate clients comprised a total of 21% of this balance as follows: Balance Percent of Total Customer 1 $ 45,635 11 % Customer 2 42,921 10 % All others 339,896 79 % Total 428,452 100 % Allowance for doubtful accounts (128,237 ) Net accounts receivable $ 300,215
Property and Equipment	Property and equipment are carried at cost. Expenditures for maintenance and repairs are expensed in the period incurred. Renewals and betterments that materially extend the life of the assets are capitalized. When assets are retired or otherwise disposed of, the cost and related accumulated depreciation are removed from the accounts, and any resulting gain or loss is reflected in income for the period. Depreciation is computed for financial statement purposes on a straight-line basis over estimated useful lives of the related assets and the modified accelerated cost recovery system for federal income tax purposes. The estimated useful lives of depreciable assets are: Estimated Useful Lives Laboratory and Computer Equipment 5 years Furniture and Fixtures 7 years Software 3 years Domains 15 years The Company’s property and equipment consisted of the following as of June 30, 2018 and September 30, 2017: June 30, 2018 September 30, 2017 Furniture and Equipment $ 182,062 $ 146,870 Laboratory Equipment 1,859,567 439,071 Software 63,913 58,333 Leasehold Improvements 139,401 41,081 Vehicles 83,915 75,165 Total 2,328,858 760,520 Accumulated depreciation (457,629 ) (213,447 ) Net value $ 1,871,229 $ 547,073 During the nine months ended June 30, 2018, the Company capitalized a total of $425,194 of equipment purchased through capital leases. There was depreciation expense of $30,705 and $14,001 and $63,796 and $22,135 recorded on equipment purchased through capital leases during the three and nine months ended June 30, 2018 and 2017, respectively.

SUMMARY OF SIGNIFICANT ACCOUN22

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	9 Months Ended
	Jun. 30, 2018
Summary Of Significant Accounting Policies
Financial assets and liabilities measured at fair value	The following table sets forth by level with the fair value hierarchy the Company’s financial assets and liabilities measured at fair value on June 30, 2018: Level 1 Level 2 Level 3 Total Liabilities Derivative financial instruments $ - $ - $ 1,579,258 $ 1,579,258 The following table sets forth by level with the fair value hierarchy the Company’s financial assets and liabilities measured at fair value on September 30, 2017: Level 1 Level 2 Level 3 Total Liabilities Derivative financial instruments $ - $ - $ 294,637 $ 294,637
Future annual payments capital lease	Future annual payments required under the capital leases through termination are as follows: Year ended September 30, Principal Interest Total 2018 $ 37,022 $ 7,463 $ 44,485 2019 152,912 20,569 173,481 2020 122,850 9,379 132,229 2021 117,637 2,343 119,980 Total $ 430,421 $ 39,754 $ 470,175
Concentration of Credit Risk	As of September 30, 2017, the Company had total accounts receivable net of allowances of $229,564. Three separate clients comprised a total of 41% of this balance as follows: Balance Percent of Total Customer 1 $ 42,878 14 % Customer 2 45,635 15 % Customer 3 37,540 12 % All others 178,294 59 % Total 304,347 100 % Allowance for doubtful accounts (74,783 ) Net accounts receivable $ 229,564 As of June 30, 2018 the Company had total accounts receivable net of allowances of $300,215. Two separate clients comprised a total of 21% of this balance as follows: Balance Percent of Total Customer 1 $ 45,635 11 % Customer 2 42,921 10 % All others 339,896 79 % Total 428,452 100 % Allowance for doubtful accounts (128,237 ) Net accounts receivable $ 300,215
Estimated useful lives of depreciable assets	Estimated Useful Lives Laboratory and Computer Equipment 5 years Furniture and Fixtures 7 years Software 3 years Domains 15 years
Plant and Equipment	June 30, 2018 September 30, 2017 Furniture and Equipment $ 182,062 $ 146,870 Laboratory Equipment 1,859,567 439,071 Software 63,913 58,333 Leasehold Improvements 139,401 41,081 Vehicles 83,915 75,165 Total 2,328,858 760,520 Accumulated depreciation (457,629 ) (213,447 ) Net value $ 1,871,229 $ 547,073

INTANGIBLE ASSETS (Tables)

INTANGIBLE ASSETS (Tables)	9 Months Ended
	Jun. 30, 2018
Intangible Assets
Schedule of impaired intangible assets	June 30, 2018 September 30, 2017 Customer list $ 1,102,462 $ 480,670 License 503,000 256,000 Favorable lease 3,100 3,100 Websites 49,574 41,965 Patent 10,278 - Intellectual property 327,180 - Non-compete agreements 183,111 - Total 2,178,705 781,735 Accumulated amortization (369,828 ) (189,475 ) Net value $ 1,808,877 $ 592,260
Schedule of future amortization associated with the intangible assets acquired	For the years ended September 30, Amortization 2018 $ 102,585 2019 410,339 2020 387,513 2021 316,214 2022 218,460 Thereafter 373,766 Total $ 1,808,877

LOANS PAYABLE (Tables)

LOANS PAYABLE (Tables)	9 Months Ended
	Jun. 30, 2018
Loans Payable Tables
Schedule of loans payable outstanding	The Company had the following loans payable outstanding as of June 30, 2018 and September 30, 2017: June 30, 2018 September 30, 2017 On March 16, 2017, the Company executed notes payable for the purchase of three vehicles. The notes carry interest at 6.637% annually and mature on March 31, 2023. $ 58,508 $ 71,039 On August 1, 2017, the Company entered into a note payable totaling $500,000 for the acquisition of Viridis (see note 3). The note carries interest at 8% annually and is due on July 1, 2018. 500,000 500,000 On September 6, 2017, the Company entered into a note payable totaling $1,000,000 for the purchase of an outstanding note receivable. The note carries interest at 8% annually and is due on July 6, 2018. 500,000 1,000,000 On August 31, 2017, the Company executed a note payable for $120,000 of which $20,000 was an original issue discount resulting in cash proceeds of $100,000. The note carries interest at 8% annually and is due on March 3, 2018. - 120,000 1,058,508 1,691,039 Less: unamortized original issue discounts (74 ) (127,662 ) Total loans payable 1,058,434 1,563,377 Less: current portion of loans payable 1,011,986 1,503,545 Long-term portion of loans payable $ 46,448 $ 59,832

CONVERTIBLE NOTES PAYABLE (Tabl

CONVERTIBLE NOTES PAYABLE (Tables)	9 Months Ended
	Jun. 30, 2018
Convertible Notes Payable
Schedule of convertible notes payable outstanding	The following table summarizes all convertible notes outstanding as of September 30, 2017: Holder Issue Date Due Date Principal Unamortized Debt Discount Carrying Value Accrued Interest Noteholder 1 3/2/2017 3/2/2018 $ 125,000 $ (38,112 ) $ 86,888 $ 5,671 Noteholder 1 7/14/2017 7/14/2018 275,600 (11,795 ) 263,805 4,712 Noteholder 1 8/14/2017 8/14/2018 275,600 (13,068 ) 262,532 2,839 Noteholder 4 3/2/2017 3/2/2018 69,000 (50,009 ) 18,991 7,187 Noteholder 4 6/5/2017 3/2/2018 125,000 (70,833 ) 54,167 3,205 Noteholder 4 7/14/2017 7/14/2018 275,600 (11,795 ) 263,805 4,470 Noteholder 4 8/14/2017 8/14/2018 275,600 (13,068 ) 262,532 2,597 $ 1,421,400 $ (208,680 ) $ 1,212,720 $ 30,681 The following table summarizes all convertible notes outstanding as of June 30, 2018: Holder Issue Date Due Date Principal Unamortized Debt Discount Carrying Value Accrued Interest Noteholder 6 4/24/2018 4/24/2019 $ 500,000 $ - $ 500,000 -

CONVERTIBLE DEBENTURES (Tables)

CONVERTIBLE DEBENTURES (Tables)	9 Months Ended
	Jun. 30, 2018
Debt Issuance Costs [Member]
Schedule of warrants assumptions table	The warrants associated with the debt issue costs were valued using a Black-Scholes model with the following assumptions: Expected term of options granted 2.00 years Expected volatility 223 % Risk-free interest rate 2.49 % Expected dividend yield 0 %
Convertible debt [Member]
Schedule of warrants assumptions table	The Company separately initially valued the detachable warrants issued with the convertible debentures at $3,351,160 using a Black-Scholes model with the following assumptions: Expected term of options granted 2.00 years Expected volatility 211-223 % Risk-free interest rate 2.09-2.25 % Expected dividend yield 0 %

DERIVATIVE LIABILITIES (Tables)

DERIVATIVE LIABILITIES (Tables)	9 Months Ended
	Jun. 30, 2018
Derivative Liabilities
Summary of derivative liabilities	The following table summarizes the derivative liabilities included in the balance sheet at June 30 2018: Fair Value of Embedded Derivative Liabilities: Balance, September 30, 2017 $ 294,637 Initial measurement of derivative liabilities 6,549,289 Change in fair market value (2,922,558 ) Write off due to conversion (2,342,112 ) Balance, June 30, 2018 $ 1,579,258
Summary of loss on derivative liability	The following table summarizes the gain (loss) on derivative liability included in the income statement for the three and nine months ended June 30, 2018 and 2017, respectively. Three Months Ended June 30, Nine Months Ended June 30, 2018 2017 2018 2017 Day one loss due to derivatives on convertible debt $ (154,548 ) $ (69,734 ) $ (765,115 ) $ (421,940 ) Change in fair value of derivatives 517,897 226,626 2,922,558 387,554 Total derivative gain (loss) $ 363,349 $ 156,892 $ 2,157,443 $ (34,386 )

ACQUISITIONS (Tables)

ACQUISITIONS (Tables)	9 Months Ended
	Jun. 30, 2018
C3 Labs, LLC [Member]
Schedule of Assets Acquired and Liabilities Assumed	ASSETS ACQUIRED Cash $ 20,468 Accounts receivable 5,110 Other current assets 3,461 Security deposits 20,000 Equipment 244,875 License 247,000 Customer list 112,000 Non-compete agreement 88,000 Goodwill 291,697 TOTAL ASSETS ACQUIRED $ 1,032,611 LIABILITIES ASSUMED Accounts payable 4,314 Deferred rent 28,297 TOTAL LIABILITIES ASSUMED 32,611 Non-controlling interest (400,000 ) NET ASSETS ACQUIRED $ 600,000
Keystone Labs, Inc. [Member]
Schedule of Assets Acquired and Liabilities Assumed	ASSETS ACQUIRED Cash $ 371,278 Accounts receivable 65,815 Prepaid expenses and other current assets 38,415 Equipment 40,774 Intellectual property 334,719 Websites and domain names 18,299 Customer list 521,539 Non-compete agreement 97,302 Goodwill 2,716,027 TOTAL ASSETS ACQUIRED $ 4,204,167 LIABILITIES ASSUMED Accounts payable 108,207 Capital lease obligation 12,826 Related party payables 153,755 Deferred revenue 5,189 TOTAL LIABILITIES ASSUMED 279,977 Non-controlling interest (1,962,095 ) NET ASSETS ACQUIRED $ 1,962,095
Leaf Detective LLC [Member]
Schedule of Assets Acquired and Liabilities Assumed	ASSETS ACQUIRED Lab supplies $ 7,715 Equipment 14,925 Goodwill 477,900 TOTAL ASSETS ACQUIRED $ 500,000

INDUSTRY SEGMENTS (Tables)

INDUSTRY SEGMENTS (Tables)	9 Months Ended
	Jun. 30, 2018
Industry Segments Tables
Summary of the Company's current segments	Nine months ended June 30, 2018 Corporate Consulting Services Testing Services Total Consolidated Revenue $ - $ 141,453 $ 2,172,061 $ 2,313,514 Segment income (loss) from operations (2,033,171 ) (2,059,269 ) (1,247,926 ) (5,340,366 ) Total assets 1,899,440 372,224 11,497,993 13,769,657 Capital expenditures - (1,038 ) (882,474 ) (883,512 ) Depreciation and amortization - 11,246 410,304 421,550 Nine months ended June 30, 2017 Corporate Consulting Services Testing Services Total Consolidated Revenue $ - $ 196,520 $ 2,081,877 $ 2,278,397 Segment income (loss) from operations (589,258 ) (192,898 ) (390,590 ) (1,172,746 ) Total assets 85,877 240,459 3,644,591 3,970,927 Capital expenditures - (1,038 ) (47,688 ) (48,726 ) Depreciation and amortization - 17,922 171,839 189,761 Three months ended June 30, 2018 Corporate Consulting Services Testing Services Total Consolidated Revenue $ - $ 38,637 $ 595,701 $ 634,338 Segment income (loss) from operations (573,239 ) (1,083,993 ) (653,134 ) (2,310,366 ) Total assets 1,899,440 372,224 11,497,993 13,769,657 Capital expenditures - - (351,998 ) (351,998 ) Depreciation and amortization - 4,075 191,500 195,575 Three months ended June 30, 2017 Corporate Consulting Services Testing Services Total Consolidated Revenue $ - $ 9,345 $ 767,873 $ 777,218 Segment income (loss) from operations (210,554 ) (197,546 ) (91,472 ) (499,572 ) Total assets 85,877 240,459 3,644,591 3,970,927 Capital expenditures - - (2,962 ) (2,962 ) Depreciation and amortization - 5,975 63,056 69,031

STOCK OPTIONS AND WARRANTS (Tab

STOCK OPTIONS AND WARRANTS (Tables)	9 Months Ended
	Jun. 30, 2018
Stock Options And Warrants
Summary of stock option and warrant activity	The following table summarizes all stock option and warrant activity for the nine months ended June 30, 2018: Shares Weighted- Average Exercise Price Per Share Outstanding, September 30, 2017 655,000 $ 0.902 Granted 4,268,049 0.795 Exercised (13,333 ) 0.600 Forfeited (70,000 ) 0.891 Expired - - Outstanding, June 30, 2018 4,839,716 $ 0.809
Schedule of outstanding and exercisable options and warrants	The following table discloses information regarding outstanding and exercisable options and warrants at June 30, 2018: Outstanding Exercisable Exercise Prices Number of Option Shares Weighted Average Exercise Price Weighted Average Remaining Life (Years) Number of Option Shares Weighted Average Exercise Price $ 0.400 120,000 $ 0.400 3.13 90,000 $ 0.400 $ 0.500 165,000 $ 0.500 3.20 123,750 $ 0.500 $ 0.600 583,966 $ 0.600 1.58 583,966 $ 0.600 $ 0.650 145,000 $ 0.650 4.32 36,250 $ 0.650 $ 0.800 3,195,750 $ 0.800 3.49 2,420,750 $ 0.800 $ 1.100 170,000 $ 1.100 4.97 42,500 $ 1.100 $ 1.260 230,000 $ 1.260 4.01 57,500 $ 1.260 $ 1.280 150,000 $ 1.280 4.80 18,750 $ 1.280 $ 1.300 10,000 $ 1.300 3.31 5,000 $ 1.300 $ 1.386 60,000 $ 1.386 4.01 15,000 $ 1.386 $ 1.666 10,000 $ 1.666 4.09 2,500 $ 1.666 Total 4,839,716 $ 0.809 3.39 3,398,466 $ 0.761
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions	June 30, 2018 Expected term of options granted 4.98 – 5.00 years Expected volatility 251-256 % Risk-free interest rate 2.01–2.25 % Expected dividend yield 0 %

COMMETTMENTS AND CONTINGECIES (

COMMETTMENTS AND CONTINGECIES (Tables)	9 Months Ended
	Jun. 30, 2018
Commettments And Contingecies
Operating Leases	Year ending September 30, 2018 168,657 2019 639,375 2020 609,812 2021 417,809 2022 291,974 2023 132,660 Total $ 2,260,290

NATURE OF ACTIVITIES AND CONT32

NATURE OF ACTIVITIES AND CONTINUANCE OF BUSINESS (Details Narrative) - Purchase Agreement [Member]	May 02, 2018	Jun. 01, 2016	Mar. 31, 2018	Dec. 29, 2017	Oct. 19, 2016	Sep. 17, 2015
Mr. Waldrop and Ms. Glauser [Member]
Common stock purchase			80.00%
C3 Labs [Member]
Acquired shares percentage				60.00%
Keystone Labs, Inc. [Member]
Common stock purchase	50.00%
Smith Scientific Industries [Member]
Common stock purchase		80.00%
Greenhaus Analytical Labs, LLC [Member]
Ownership percentage					100.00%
CR Labs [Member]
Acquired shares percentage						80.00%

SUMMARY OF SIGNIFICANT ACCOUN33

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)	Jun. 30, 2018	Sep. 30, 2017
Liabilities
Derivative financial instruments	$ 1,579,258	$ 294,637
Level 1 [Member]
Liabilities
Derivative financial instruments
Level 2 [Member]
Liabilities
Derivative financial instruments
Level 3 [Member]
Liabilities
Derivative financial instruments	$ 1,579,258	$ 294,637

SUMMARY OF SIGNIFICANT ACCOUN34

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)	Jun. 30, 2018USD ($)
2,018	$ 44,485
2,019	173,481
2,020	132,229
2,021	119,980
Total	470,175
Interest [Member]
2,018	7,463
2,019	20,569
2,020	9,379
2,021	2,343
Total	39,754
Principal [Member]
2,018	37,022
2,019	152,912
2,020	122,850
2,021	117,637
Total	$ 430,421

SUMMARY OF SIGNIFICANT ACCOUN35

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 2) - USD ($)	9 Months Ended	12 Months Ended
	Jun. 30, 2018	Sep. 30, 2017
Total	$ 428,452	$ 304,347
Allowance for doubtful accounts	(128,237)	(74,783)
Net accounts receivable	$ 300,215	$ 229,564
Concentration of Credit Risk percentage	100.00%	100.00%
Customer 1 [Member]
Total	$ 45,635	$ 42,878
Concentration of Credit Risk percentage	11.00%	14.00%
Customer 2 [Member]
Total	$ 42,921	$ 45,635
Concentration of Credit Risk percentage	10.00%	15.00%
Customer 3 [Member]
Total		$ 37,540
Concentration of Credit Risk percentage		12.00%
All others [Member]
Total	$ 339,896	$ 178,294
Concentration of Credit Risk percentage	79.00%	59.00%

SUMMARY OF SIGNIFICANT ACCOUN36

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 3)	9 Months Ended
	Jun. 30, 2018
Laboratory and Computer Equipment [Member]
Estimated useful life	5 years
Furniture and Fixtures [Member]
Estimated useful life	7 years
Software [Member]
Estimated useful life	3 years
Domains [Member]
Estimated useful life	15 years

SUMMARY OF SIGNIFICANT ACCOUN37

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 4) - USD ($)	Jun. 30, 2018	Sep. 30, 2017
Total	$ 2,328,858	$ 760,520
Accumulated depreciation	(457,629)	(213,447)
Net value	1,871,229	547,073
Furniture and Equipment [Member]
Total	182,062	146,870
Laboratory Equipment [Member]
Total	1,859,567	439,071
Software [Member]
Total	63,913	58,333
Leasehold Improvements [Member]
Total	139,401	41,081
Vehicles [Member]
Total	$ 83,915	$ 75,165

SUMMARY OF SIGNIFICANT ACCOUN38

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	Feb. 02, 2018	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017	Sep. 30, 2017
Summary Of Significant Accounting Policies Details Abstract
Potentially dilutive common shares outstanding				13,666,226	10,071,182
Note receivable		$ 1,300,000		$ 1,300,000		$ 1,300,000
Capital lease obligation, current		153,555		153,555		37,990
Accounts receivable, net of allowance		300,215		300,215		229,564
Capital lease obligation, noncurrent portion		276,866		276,866		52,777
Net present value of leased equipment	$ 425,194	425,194		425,194		116,800
Net present value of leased equipment, Description	The Company determined this was a capital lease based on the minimum buy out price and capitalized the net present value of the lease of $385,208 plus the required up front cash payment of $39,986 which totaled $425,194 as equipment.
Capital lease future payment		470,175		$ 470,175		$ 111,501
Future payment due date				March 2,021		December 2,019
Financing charges		39,754		$ 39,754		$ 20,734
Total principal balance		430,421		430,421		90,967
Cash, FDIC Insured Amount		250,000		250,000		250,000
Depreciation expense		30,705	$ 14,001	$ 63,796	$ 22,135
Lease termination description				the Company entered into three separate long-term leases for equipment that contain a $1 buyout option upon lease termination.
Cash held in excess of FDIC limit		$ 815,877		$ 815,877		$ 0

INTANGIBLE ASSETS (Details)

INTANGIBLE ASSETS (Details) - USD ($)	Jun. 30, 2018	Sep. 30, 2017
Total	$ 2,178,705	$ 781,735
Accumulated amortization	(369,828)	(189,475)
Net value	1,808,877	592,260
Customer Lists [Member]
Total	1,102,462	480,670
License [Member]
Total	503,000	256,000
Favorable lease [Member]
Total	3,100	3,100
Website [Member]
Total	49,574	41,965
Patent [Member]
Total	10,278
Intellectual property [Member]
Total	327,180
Non-compete agreement [Member]
Total	$ 183,111

INTANGIBLE ASSETS (Details 1)

INTANGIBLE ASSETS (Details 1) - USD ($)	Jun. 30, 2018	Sep. 30, 2017
Total	$ 1,808,877	$ 592,260
Amortization [Member]
2,018	102,585
2,019	410,339
2,020	387,513
2,021	316,214
2,022	218,460
Thereafter	373,766
Total	$ 1,808,877

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)	Mar. 05, 2018	Sep. 06, 2017	Nov. 01, 2016	Jun. 01, 2016	Apr. 19, 2018	Aug. 31, 2017	Oct. 19, 2016	May 24, 2016	Jun. 30, 2018	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017	Sep. 30, 2017	Sep. 30, 2016	May 02, 2018
Proceeds from notes payable - related party													$ 80,100
Current Portion - Notes Payable - Related Party									$ 26,660	$ 26,660		26,660		$ 0
Repayment to related party												20,000		22,050
Notes Payable - Related Party, less Current Portion									1,083,530	1,083,530		1,083,530		1,251,306
Unamortized Debt discount						$ 20,000			0	0		0		208,680
Debt discount					$ 29,044
Maturity date		Jul. 6, 2018				Mar. 3, 2018
Principal balance									$ 430,421	$ 430,421		$ 430,421		$ 90,967
Common stock shares issued									19,719,903	19,719,903		19,719,903		10,732,922
Common Stock, value									$ 1,972	$ 1,972		$ 1,972		$ 1,073
Losses on extinguishment of debt												(56,093)
Debt conversion original amount					$ 85,000							1,414,907
Outstanding principal balance percentages					25.00%
Debt conversion, description					The Company at the holder’s option at a rate equal to 80% of the lowest close price in the prior five trading days
Interest expense									2,384
Related party loan payable									1,058,434	1,058,434		1,058,434		1,563,377
Deposits, related party									180,000	180,000		$ 180,000
Related party description												the Company determined do not pursue the development of the software and the related party agreed it would return the $200,000
Related party return amount												$ 20,000
Outstanding remaining balance									180,000	180,000		180,000
Relate party Agreement [Member]
Interest rate	8.00%
Current Portion - Notes Payable - Related Party	$ 200,000
Maturity date	Mar. 5, 2021
Description of common stock discretion	Common stock of the issuer at the Company’s discretion at $0.03 per share.
Chief Science Officer [Member]
Borrowed amount															$ 16,200
Due to related parties									0	0		0		9,200
Repayment to related party												9,200		7,000
Green Style Consulting, LLC [Member]
Company repaid												24,328		6,090
Due to related parties									19,582	19,582		19,582		43,910
Interest rate			5.00%
Current Portion - Notes Payable - Related Party			$ 50,000
Unamortized note premium									1,250	1,250		1,250		4,028
Premium on fair value			$ 7,416
Future net profit							$ 15,809
Maturity date			Oct. 31, 2018
Accrued interest												705		2,055
Account payable									15,809	15,809		15,809		15,809
Keystone Labs, Inc. [Member]
Repayment to related party												22,340
Principal balance									131,415	131,415		131,415
Related party loan payable																$ 153,755
Greenhaus Analytical Services, LLC [Member]
Due to related parties							$ 340,000
Interest rate							6.00%
Current Portion - Notes Payable - Related Party							$ 340,000		26,660	26,660		26,660		0
Unamortized Debt discount									58,375	58,375		58,375		42,044
Debt discount							$ 55,277
Maturity date							Oct. 16, 2020
Principal balance									340,000	340,000		340,000		340,000
Accrued interest												34,764		19,506
Convertible debt									85,000	85,000		85,000		0
Henry Grimmett [Member]
Quarterly payments							$ 25,000
Company repaid												2,000		25,100
Due to related parties							$ 194,512		117,412	117,412		117,412		169,412
Interest rate							0.00%
Short-term loan									50,000	50,000		50,000
Long-term note									$ 67,412	$ 67,412		$ 67,412
Common stock shares issued									125,000	125,000		125,000
Common Stock, value									$ 62,500	$ 62,500		$ 62,500
Extinguishment of debt amount												50,000
Losses on extinguishment of debt												15,000
Anthony Smith [Member]
Acquisition of business, amount				$ 636,000
Percentage owned				80.00%
Company repaid												25,000		50,000
Due to related parties									$ 236,000	$ 236,000		$ 236,000		261,000
Interest rate									5.00%	5.00%		5.00%
Series C Convertible Preferred Stock, Shares Issued				300,000
Preferred Stock value				$ 135,000
Short-term loan				$ 336,000
Accrued interest												$ 27,986		18,846
Sara Lausmann [Member]
Borrowed amount								$ 972,500
Due to related parties									$ 610,370	$ 610,370		$ 610,370		689,870
Interest rate									5.00%	5.00%		5.00%
Current Portion - Notes Payable - Related Party									$ 74,370	$ 74,370		$ 74,370		89,870
Repayment to related party												79,500		82,630
Notes Payable - Related Party, less Current Portion									536,000	536,000		536,000		600,000
Series C Convertible Preferred Stock, Shares Issued								200,000
Preferred Stock value								$ 80,000
Short-term loan								72,500
Long-term note								$ 700,000
Accrued interest												71,830		47,409
Eric Ezrine, CR Labs, President [Member]
Due to related parties									130	130		130		$ 130
Interest rate														0.00%
Payment of severance agreement														$ 44,500
Repayment to related party														13,139
Account payable									2,450	2,450		2,450		22,450
Chief Executive Officer [Member]
Proceeds from notes payable - related party														80,100
Due to related parties									0	0		0		4,450
Repayment to related party												4,450		75,650
Newport Commercials Advisors [Member]
Management consulting services expenses										100,000	$ 7,858	114,317	$ 35,530
Chief Operating Officer [Member]
Borrowed amount														106,000
Due to related parties									$ 0	$ 0		0		84,205
Repayment to related party												$ 84,205		$ 21,795

STOCKHOLDERS' EQUITY (Details N

STOCKHOLDERS' EQUITY (Details Narrative) - USD ($)	1 Months Ended	9 Months Ended
	Apr. 19, 2018	Jun. 30, 2018	Jun. 30, 2017	Sep. 30, 2017
Common stock, par value		$ 0.0001		$ 0.0001
Common stock, shares authorized		1,000,000,000		1,000,000,000
Common stock, shares issued		19,719,903		10,732,922
Common stock, shares outstanding		19,719,903		10,732,922
Common shares issued for cash proceeds, Amount		$ 2,041,501
Common shares issued for cash proceeds, Shares		2,561,392
Common shares issued for equity incentive plan, Shares		197,000
Common shares issued for services valued, Amount		$ 265,527
Common shares issued for services valued, Shares		222,750
Conversion of Convertible note and accrued interest into common stock, Shares		144,852
Conversion of Convertible note and accrued interest into common stock, Amount		$ 75,373
Debt conversion converted instrument shares issued		670,271
Debt conversion original amount	$ 85,000	$ 1,414,907
Settlement of common share in accounts payable, share		37,500
Settlement of accounts payable		$ 15,000
Common stock shares issued upon settlement of non-convertible debt		324,000
Non-convertible debt extinguished		$ 122,157
Share based compensation expense		$ 439,210
Exercise of outstanding warrants		13,333
Proceeds from exercise of warrants		$ 7,999
Convertible Notes Payable [Member]
Debt conversion converted instrument shares issued		3,990,883
Debt conversion original amount		$ 2,197,000
Related party [Member]
Common stock shares issued upon settlement of non-convertible debt		125,000
Non-convertible debt extinguished		$ 50,000
Series D Preferred Stock [Member]
Convertible Preferred Stock, Par Value		$ 0.0001		$ 0.0001
Convertible Preferred Stock, Shares Authorized		1,000,000		1,000,000
Convertible Preferred Stock, Shares Issued		552,500		832,500
Convertible Preferred Stock, Shares Outstanding		552,500		832,500
Convertible preferred stock, shares converted		280,000
Stock conversion converted instrument shares issued		700,000
Series C Preferred Stock [Member]
Convertible Preferred Stock, Par Value		$ 0.0001		$ 0.0001
Convertible Preferred Stock, Shares Authorized		500,000		500,000
Convertible Preferred Stock, Shares Issued		500,000		500,000
Convertible Preferred Stock, Shares Outstanding		500,000		500,000
Series B Preferred Stock [Member]
Convertible Preferred Stock, Par Value		$ 0.0001		$ 0.0001
Convertible Preferred Stock, Shares Authorized		5,000,000		5,000,000
Convertible Preferred Stock, Shares Issued		5,000,000		5,000,000
Convertible Preferred Stock, Shares Outstanding		5,000,000		5,000,000
Series A Preferred Stock [Member]
Convertible Preferred Stock, Par Value		$ 0.0001		$ 0.0001
Convertible Preferred Stock, Shares Authorized		1,850,000		1,850,000
Convertible Preferred Stock, Shares Issued		0		0
Convertible Preferred Stock, Shares Outstanding		0		0

LOANS PAYABLE (Details)

LOANS PAYABLE (Details) - USD ($)	Jun. 30, 2018	Sep. 30, 2017
Loan Payable	$ 1,058,508	$ 1,691,039
Less: unamortized original issue discounts	(74)	(127,662)
Total loans payable	1,058,434	1,563,377
Less: current portion of loans payable	1,011,986	1,503,545
Long-term portion of loans payable	46,448	59,832
Loans Payable One [Member]
Loan Payable	58,508	71,039
Loans Payable Two [Member]
Loan Payable	500,000	500,000
Loans Payable Three [Member]
Loan Payable	500,000	1,000,000
Loans Payable Four [Member]
Loan Payable		$ 120,000

LOANS PAYABLE (Details Narrativ

LOANS PAYABLE (Details Narrative) - USD ($)	Sep. 06, 2017	Aug. 01, 2017	Aug. 31, 2017	Mar. 16, 2017	Jun. 30, 2018	Sep. 30, 2017
Loan payable	$ 1,000,000		$ 120,000
Debt discount			$ 20,000		$ 0	$ 208,680
Interest rate	8.00%		8.00%
Maturity date	Jul. 6, 2018		Mar. 3, 2018
Cash proceeds from loans payable			$ 100,000
Purchase and Sale of Future Receivables agreement [Member]
Interest rate				6.637%
Maturity date				Mar. 31, 2023
Purchase and Sale of Future Receivables agreement [Member]
Loan payable		$ 500,000
Interest rate		8.00%
Maturity date		Jul. 1, 2018
Loans Payable [Member]
Accrued interest					59,760	$ 12,625
Acquisition [Member] | C3 Labs [Member]
Notes payable					$ 100,000

CONVERTIBLE NOTES PAYABLE (Deta

CONVERTIBLE NOTES PAYABLE (Details) - USD ($)	9 Months Ended	12 Months Ended
	Jun. 30, 2018	Sep. 30, 2017	Aug. 31, 2017
Principal amount		$ 1,421,400
Unamortized Debt Discount	$ 0	(208,680)	$ (20,000)
Carrying Value		1,212,720
Accrued Interest		$ 30,681
Noteholder 1 [Member]
Issue Date		Mar. 2, 2017
Due Date		Mar. 2, 2018
Principal amount		$ 125,000
Unamortized Debt Discount		(38,112)
Carrying Value		86,888
Accrued Interest		$ 5,671
Noteholder 1 One [Member]
Issue Date		Jul. 14, 2017
Due Date		Jul. 14, 2018
Principal amount		$ 275,600
Unamortized Debt Discount		(11,795)
Carrying Value		263,805
Accrued Interest		$ 4,712
Noteholder 1 Two [Member]
Issue Date		Aug. 14, 2017
Due Date		Aug. 14, 2018
Principal amount		$ 275,600
Unamortized Debt Discount		(13,068)
Carrying Value		262,532
Accrued Interest		$ 2,839
Noteholder 4 [Member]
Issue Date		Mar. 2, 2017
Due Date		Mar. 2, 2018
Principal amount		$ 69,000
Unamortized Debt Discount		(50,009)
Carrying Value		18,991
Accrued Interest		$ 7,187
Noteholder 4 One [Member]
Issue Date		Jun. 5, 2017
Due Date		Mar. 2, 2018
Principal amount		$ 125,000
Unamortized Debt Discount		(70,833)
Carrying Value		54,167
Accrued Interest		$ 3,205
Noteholder 4 Two [Member]
Issue Date		Jul. 14, 2017
Due Date		Jul. 14, 2018
Principal amount		$ 275,600
Unamortized Debt Discount		(11,795)
Carrying Value		263,805
Accrued Interest		$ 4,470
Noteholder 4 Three [Member]
Issue Date		Aug. 14, 2017
Due Date		Aug. 14, 2018
Principal amount		$ 275,600
Unamortized Debt Discount		(13,068)
Carrying Value		262,532
Accrued Interest		$ 2,597
Noteholder 6 [Member]
Issue Date	Apr. 24, 2018
Due Date	Apr. 24, 2019
Principal amount	$ 500,000
Unamortized Debt Discount
Carrying Value	500,000
Accrued Interest

CONVERTIBLE NOTES PAYABLE (De46

CONVERTIBLE NOTES PAYABLE (Details Narrative) - USD ($)	Sep. 06, 2017	Aug. 31, 2017	Jun. 30, 2018	Sep. 30, 2017
Convertible promissory note principal amount				$ 1,421,400
Maturity date of note	Jul. 6, 2018	Mar. 3, 2018
Debt conversion converted instrument shares issued			670,271
Total convertible note payable			$ 58,340
Noteholder 1 [Member]
Convertible promissory note principal amount				$ 125,000
July 14, 2017 [Member] | Transaction 1 [Member] | Noteholder 1 [Member]
Cash proceeds from convertible promissory note			$ 250,000
Maturity date of note			Jul. 14, 2018
Debt conversion converted instrument shares issued			593,345
Description of conversion of note payable			The Note is convertible into the Company's common stock commencing 180 days from the date of issuance at a conversion price equal to 75% of the lowest trade price of the Company's common stock for the fifteen prior trading days including the date of conversion.
Converted shares during accrued interest			651,836	27,976
August 14, 2017 [Member] | Transaction 2 [Member] | Noteholder 1 [Member]
Convertible principal balance				$ 275,600
Accrued interest due				2,839
March 2, 2017 [Member] | Transaction [Member] | Noteholder 1 [Member]
Convertible promissory note principal amount			$ 125,000
Annual interest rate			8.00%
Accrued interest on note			$ 0	7,397
Convertible principal balance			$ 0	125,000
Noteholder 6 [Member] | On April 24, 2018 [Member] | Leaf Detective LLC [Member]
Maturity date of note			Apr. 24, 2019
Convertible principal balance			$ 500,000
Convertible outstanding principal balance			$ 500,000	0
Convertible exchange interest rate			100.00%
Average trading price per share			$ 1.25
Description of trading price			In the event the average lowest trading price of the Company’s common stock during the five days prior to maturity is less than $1.25 per share, the Company will pay the noteholder the difference between $1.25 and the average lowest trading price during the preceding five days per share converted in cash
Noteholder 5 [Member] | On January 1, 2018 [Member] | C3 Labs, LLC [Member]
Maturity date of note			Jun. 30, 2018
Convertible principal balance			$ 500,000	0
Debt conversion converted instrument shares issued			666,667
Convertible outstanding principal balance			$ 0
Debt conversion amount converted			500,000
Total convertible note payable			$ 500,000
Convertible exchange interest rate			60.00%
Average trading price per share			$ 0.75
Description of trading price			In the event the average trading price of the Company’s common stock during the five days prior to maturity is less than $0.75 per share, the Company will pay the noteholder the difference between $0.75 and the average trading price during the preceding five days per share converted in cash.
Noteholder 4 [Member] | July 14, 2017 [Member]
Convertible promissory note principal amount			$ 275,600
Discount on convertible promissory note			15,600
Cash proceeds from convertible promissory note			$ 250,000
Annual interest rate			8.00%
Maturity date of note			Jul. 14, 2018
Accrued interest on note			$ 0	0
Convertible principal balance			$ 0	0
Description of conversion of note payable			The Note is convertible into the Company's common stock commencing 180 days from the date of issuance at a conversion price equal to 75% of the lowest trade price of the Company's common stock for the fifteen prior trading days including the date of conversion.
Amount paid to third party			$ 10,000
Noteholder 1 [Member] | July 14, 2017 [Member] | Transaction 1 [Member]
Convertible promissory note principal amount			275,600
Discount on convertible promissory note			$ 15,600
Annual interest rate			8.00%
Accrued interest on note			$ 12,354
Convertible principal balance			0	275,600
Amount paid to third party			10,000
Accrued interest due			0	$ 4,712
Noteholder 1 [Member] | August 14, 2017 [Member] | Transaction 2 [Member]
Convertible promissory note principal amount			275,600
Discount on convertible promissory note			15,600
Cash proceeds from convertible promissory note			$ 250,000
Annual interest rate			8.00%
Maturity date of note			Aug. 14, 2018
Accrued interest on note			$ 15,464
Convertible principal balance			$ 0
Description of conversion of note payable			The Note is convertible into the Company's common stock commencing 180 days from the date of issuance at a conversion price equal to 75% of the lowest trade price of the Company's common stock for the fifteen prior trading days including the date of conversion.
Amount paid to third party			$ 10,000
Accrued interest due			$ 0
Converted shares during accrued interest			403,809	22,658
Noteholder 1 [Member] | March 2, 2017 [Member] | Transaction [Member]
Cash proceeds from convertible promissory note			$ 125,000
Maturity date of note			Mar. 2, 2018
Debt conversion converted instrument shares issued			325,562
Description of conversion of note payable			The Note is convertible into the Company's common stock commencing 180 days from the date of issuance at a conversion price equal to 65% of the lowest trade price of the Company's common stock for the twenty prior trading days including the date of conversion.
Debt conversion amount converted			$ 125,000

CONVERTIBLE DEBENTURES (Details

CONVERTIBLE DEBENTURES (Details)	9 Months Ended
	Jun. 30, 2018
Expected dividend yield	0.00%
Debt Issuance Costs [Member]
Expected term of options granted	2 years
Expected volatility	223.00%
Risk-free interest rate	2.49%
Expected dividend yield	0.00%

CONVERTIBLE DEBENTURES (Detai48

CONVERTIBLE DEBENTURES (Details 1)	9 Months Ended
	Jun. 30, 2018
Expected dividend yield	0.00%
Minimum [Member]
Expected term of options granted	4 years 11 months 23 days
Expected volatility	251.00%
Risk-free interest rate	2.01%
Maximum [Member]
Expected term of options granted	5 years
Expected volatility	256.00%
Risk-free interest rate	2.25%
Convertible debt [Member]
Expected term of options granted	2 years
Expected dividend yield	0.00%
Convertible debt [Member] | Minimum [Member]
Expected volatility	211.00%
Risk-free interest rate	2.09%
Convertible debt [Member] | Maximum [Member]
Expected volatility	223.00%
Risk-free interest rate	2.25%

CONVERTIBLE DEBENTURES (Detai49

CONVERTIBLE DEBENTURES (Details Narrative) - USD ($)	1 Months Ended	9 Months Ended
	Jan. 29, 2018	Jun. 30, 2018	Jun. 30, 2017	Sep. 30, 2017
Proceeds from issuance of convertible debt		$ 6,136,120
Common Stock, per share		$ 0.0001		$ 0.0001
Common Stock, value		$ 1,972		$ 1,073
Outstanding principal		$ 6,583,000
Total number of convertible shares		670,271
Convertible debentures payable, net of discounts		$ 900,471
Unamortized debt discount		5,682,529		$ 0
Principal and accrued interest		$ 184,287
Unsecured Convertible Debentures [Member]
Number of units issued	5,973
Interest rate	8.00%
Principal face value	$ 1,000
Number of warrants	250
Proceeds from issuance of unsecured convertible debt	$ 5,973,000
Warrant exercise price	$ 0.80
Warrant period	24 months
Maturity date, description	The convertible debentures have a maturity date of 36 months from issuance.
Simple interest rate	8.00%
Convertible, conversion price per share	$ 0.60
Separate Debenture [Member]
Convertible, conversion price per share		$ 0.60
Warrants issued		152,500
Proceeds from issuance of convertible debt		$ 610,000
Common Stock, per share		$ 0.80
Convertible Debenture [Member]
Interest rate		6.00%
Warrant exercise price		$ 0.60
Warrant period		2 years
Warrants issued		597,300
Common Stock, per share		$ 0.60
Convertible debt, issuance cost		$ 702,963
Common Stock, value		1,414,907
Proceeds from purchase of common stock		1,265,385
Debt issuance costs		3,383,255
Detachable warrants issued, valued		3,351,160
Outstanding principal		$ 6,583,000
Total number of convertible shares		10,971,667
Convertible Debenture One [Member]
Warrants issued		4,616,545
Debt issuance costs		$ 6,583,000
Debt discount		$ 4,465,131

DERIVATIVE LIABILITY (Details)

DERIVATIVE LIABILITY (Details) - Derivative Liability [Member]	9 Months Ended
	Jun. 30, 2018USD ($)
Beginning Balance	$ 294,637
Initial measurement of derivative liabilities	6,549,289
Change in fair market value	(2,922,558)
Write off due to conversion	(2,342,112)
Ending Balance	$ 1,579,258

DERIVATIVE LIABILITY (Details 1

DERIVATIVE LIABILITY (Details 1) - USD ($)	3 Months Ended		9 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Total derivative gain (loss)	$ 363,349	$ 156,892	$ 2,157,443	$ (34,386)
Derivative Liability [Member]
Day one loss due to derivatives on convertible debt	(154,548)	(69,734)	(765,115)	(421,940)
Change in fair value of derivatives	517,897	226,626	2,922,558	387,554
Total derivative gain (loss)	$ 363,349	$ 156,892	$ 2,157,443	$ (34,386)

DERIVATIVE LIABILITY (Details N

DERIVATIVE LIABILITY (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017	Sep. 30, 2017
Gain (loss) on change in fair market value of derivative liabilities	$ (363,349)	$ (156,892)	$ (2,157,443)	$ 34,386
Reclassification of derivative liability to additional paid in capital			2,342,112	$ 1,188,126
Convertible promissory note principal amount					$ 1,421,400
Convertible Notes Payable Seven [Member]
Aggregate fair value	0		0
Derivative liability due to conversion	404,548		$ 404,548
Expected volatility rate			129.00%
Risk-free interest rate			1.86%
Expected life			3 months 11 days
Convertible promissory note principal amount	275,600		$ 275,600
Convertible Notes Payable Six [Member]
Gain (loss) on change in fair market value of derivative liabilities			173
Aggregate fair value	29,217		$ 29,217
Expected volatility rate			128.00%
Risk-free interest rate			2.55%
Expected life			2 years 3 months 19 days
Convertible Notes Payable Six [Member] | July 14, 2017 [Member]
Convertible promissory notes	275,600		$ 275,600
Aggregate fair value	404,548		404,548
Debt discount	250,000		250,000
Fair value at initial measurement of derivative liability	154,548		$ 154,548
Convertible Notes Payable Six [Member] | July 14, 2017 [Member]
Maturity date			Jul. 14, 2018
Interest rate			8.00%
Conversion rate, description			the conversion rate equal to a 25% discount from the lowest trading price in the fifteen trading days prior to conversion.
Convertible Notes Payable Five [Member]
Gain (loss) on change in fair market value of derivative liabilities			$ 177,523
Aggregate fair value	0		0
Derivative liability due to conversion	446,879		$ 446,879
Expected volatility rate			129.00%
Risk-free interest rate			1.88%
Expected life			3 months 15 days
Convertible promissory note principal amount	275,600		$ 275,600
Convertible Notes Payable Five [Member] | April 16, 2018 [Member]
Convertible promissory notes	85,000		$ 85,000
Interest rate			6.00%
Conversion rate, description			the conversion rate equal to a 20% discount from the lowest trading price in the five trading days prior to conversion.
Aggregate fair value	29,044		$ 29,044
Debt discount	29,044		29,044
Convertible promissory note principal amount	340,000		340,000
Convertible Notes Payable Four [Member]
Gain (loss) on change in fair market value of derivative liabilities			13,917
Aggregate fair value	0		0
Derivative liability due to conversion	316,361		$ 316,361
Expected volatility rate			128.00%
Risk-free interest rate			1.81%
Expected life			6 months
Convertible promissory note principal amount	275,600		$ 275,600
Convertible Notes Payable Four [Member] | August 14, 2017 [Member]
Convertible promissory notes	275,600		$ 275,600
Maturity date			Aug. 14, 2018
Interest rate			8.00%
Conversion rate, description			conversion rate equal to a 25% discount from the lowest trading price in the fifteen trading days prior to conversion.
Aggregate fair value	329,356		$ 329,356
Debt discount	260,000		260,000
Fair value at initial measurement of derivative liability	69,356		69,356
Convertible Notes Payable Three [Member]
Gain (loss) on change in fair market value of derivative liabilities			8,276
Aggregate fair value	0		0
Derivative liability due to conversion	411,520		$ 411,520
Expected volatility rate			128.00%
Risk-free interest rate			1.85%
Expected life			26 days
Convertible promissory note principal amount	275,600		$ 275,600
Convertible Notes Payable Three [Member] | August 14, 2017 [Member]
Convertible promissory notes	275,600		$ 275,600
Maturity date			Aug. 14, 2018
Interest rate			8.00%
Conversion rate, description			conversion rate equal to a 25% discount from the lowest trading price in the fifteen trading days prior to conversion.
Aggregate fair value	330,278		$ 330,278
Debt discount	260,000		260,000
Fair value at initial measurement of derivative liability	70,278		70,278
Convertible Notes Payable Two [Member]
Gain (loss) on change in fair market value of derivative liabilities			64,148
Aggregate fair value	0		0
Derivative liability due to conversion	355,574		$ 355,574
Expected volatility rate			128.00%
Risk-free interest rate			1.84%
Expected life			2 months 19 days
Convertible promissory note principal amount	275,600		$ 275,600
Convertible Notes Payable Two [Member] | July 14, 2017 [Member]
Convertible promissory notes	275,600		$ 275,600
Maturity date			Jul. 14, 2018
Interest rate			8.00%
Conversion rate, description			conversion rate equal to a 25% discount from the lowest trading price in the fifteen trading days prior to conversion.
Aggregate fair value	419,796		$ 419,796
Debt discount	260,000		260,000
Fair value at initial measurement of derivative liability	159,796		159,796
Convertible Notes Payable One [Member] | July 14, 2017 [Member]
Convertible promissory notes	275,600		$ 275,600
Maturity date			Jul. 14, 2018
Interest rate			8.00%
Conversion rate, description			conversion rate equal to a 25% discount from the lowest trading price in the fifteen trading days prior to conversion.
Aggregate fair value	419,722		$ 419,722
Debt discount	260,000		260,000
Fair value at initial measurement of derivative liability	159,722		159,722
Convertible debt [Member]
Gain (loss) on change in fair market value of derivative liabilities			1,550,041
Convertible debt	$ 6,583,000		$ 6,583,000
Maturity date, description			January 29, 2021 to March 8, 2021
Warrant issued to purchase of common stock	2,243,050		2,243,050
Aggregate fair value	$ 4,616,545		$ 4,616,545
Debt discount	4,465,131		4,465,131
Fair value at initial measurement of derivative liability	151,414		151,414
Change in fair value of derivatives			$ 3,054,253
Risk-free interest rate			2.52%
Change in fair value due to warrant exercise			$ 12,251
Convertible debt [Member] | Minimum [Member]
Expected volatility rate			118.00%
Warrant exercise price			$ 0.60
Expected life			1 year 7 months 2 days
Convertible debt [Member] | Maximum [Member]
Expected volatility rate			129.00%
Warrant exercise price			$ 0.80
Expected life			1 year 8 months 9 days
Convertible Notes Payable [Member]
Derivative liability	1,579,258		$ 1,579,258		$ 294,637
Gain (loss) on change in fair market value of derivative liabilities	$ 363,349		$ 2,157,443

ACQUISITIONS (Details)

ACQUISITIONS (Details) - USD ($)	Jun. 30, 2018	Sep. 30, 2017
ASSETS ACQUIRED
Other current assets	$ 122,225	$ 7,438
Goodwill	6,343,593	$ 2,958,137
C3 Labs, LLC [Member]
ASSETS ACQUIRED
Cash	20,468
Accounts receivable	5,110
Other current assets	3,461
Security deposits	20,000
Equipment	244,875
License	247,000
Customer list	112,000
Non-compete agreement	88,000
Goodwill	291,697
TOTAL ASSETS ACQUIRED	1,032,611
Accounts payable	4,314
Deferred rent	28,297
TOTAL LIABILITIES ASSUMED	32,611
Non-controlling interest	(400,000)
NET ASSETS ACQUIRED	$ 600,000

ACQUISITIONS (Details 1)

ACQUISITIONS (Details 1) - USD ($)	Jun. 30, 2018	Sep. 30, 2017
ASSETS ACQUIRED
Goodwill	$ 6,343,593	$ 2,958,137
Keystone Labs, Inc. [Member]
ASSETS ACQUIRED
Cash	371,278
Accounts receivable	65,815
Prepaid expenses and other current assets	38,415
Equipment	40,774
Intellectual property	334,719
Websites and domain names	18,299
Customer list	521,539
Non-compete agreement	97,302
Goodwill	2,716,027
TOTAL ASSETS ACQUIRED	4,204,167
Accounts payable	108,207
Capital lease obligation	12,826
Related party payables	153,755
Deferred rent	5,189
TOTAL LIABILITIES ASSUMED	279,977
Non-controlling interest	(1,962,095)
NET ASSETS ACQUIRED	$ 1,962,095

ACQUISITIONS (Details 2)

ACQUISITIONS (Details 2) - USD ($)	Jun. 30, 2018	Sep. 30, 2017
ASSETS ACQUIRED
Goodwill	$ 6,343,593	$ 2,958,137
Leaf Detective LLC [Member]
ASSETS ACQUIRED
Lab supplies	7,715
Equipment	14,925
Goodwill	477,900
TOTAL ASSETS ACQUIRED	$ 500,000

ACQUISITIONS (Details Narrative

ACQUISITIONS (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017	Sep. 30, 2017
Convertible notes payable, issued	$ 58,340		$ 58,340
Proceeds from convertible notes payable			$ 6,136,120
Non-compete agreement period			5 years
Total revenues	$ 634,338	$ 777,218	$ 2,313,514	$ 2,278,397
Intellectual property [Member]
Amortization period			5 years
Non-compete agreements [Member]
Amortization period			2 years
Website And Domain Names [Member]
Amortization period			2 years
Customer list [Member]
Amortization period			7 years
License [Member]
Amortization period			7 years
Customer Lists [Member]
Amortization period			7 years
Purchase Agreement [Member]
Ownership percentage	60.00%		60.00%
Promissory notes, issued	$ 100,000		$ 100,000
Convertible promissory notes, issued	$ 500,000		500,000
Proceeds from convertible notes payable			600,000
Leaf Detective LLC [Member] | April 29, 2018 to June 30, 2018 [Member]
Total revenues			$ 7,560
Leaf Detective LLC [Member] | April 29, 2018 [Member] | Asset Purchase Agreement [Member]
Convertible, conversion price per share	$ 1.25		$ 1.25
Maturity date description			bears no interest and has a maturity of 12 months from the closing of the Agreement.
Convertible promissory notes, issued	$ 500,000		$ 500,000
Keystone Labs, Inc. [Member]
Cash	$ 371,278		371,278
Keystone Labs, Inc. [Member] | May 2, 2018 to June 30, 2018 [Member]
Total revenues			$ 73,284
Keystone Labs, Inc. [Member] | May 2, 2018 [Member]
Acquisition percentage	50.00%		50.00%
Keystone Labs, Inc. [Member] | May 2, 2018 [Member] | Canadian Dollars [Member]
Cash	$ 2,495,000		$ 2,495,000
Keystone Labs, Inc. [Member] | May 2, 2018 [Member] | Asset Purchase Agreement [Member]
Acquisition paid	1,962,095		1,962,095
C3 Labs, LLC [Member]
Cash	$ 20,468		$ 20,468
C3 Labs, LLC [Member] | January 1, 2018 [Member] | Convertible Notes Payable [Member]
Ownership percentage	60.00%		60.00%
Convertible notes payable, issued	$ 500,000		$ 500,000
Maturity date			Jun. 30, 2018
Convertible, conversion price per share	$ 0.75		$ 0.75
Notes payable, issued	$ 100,000		$ 100,000
C3 Labs, LLC [Member] | January 1, 2018 [Member] | Notes payble [Member]
Maturity date			Mar. 31, 2018
C3 Labs, LLC [Member] | January 1, 2018 [Member] | Option One [Member]
Option to purchase of additional interest, description			a) 30% Option. Effective as of Closing and terminating the date three (3) years from the Closing Date, the C3 Members hereby collectively grant EVIO the right to ratably purchase from the C3 Members an aggregate of 30% of the Interests in C3 LABS following the issuance of 60% of the Interests to EVIO. EVIO may exercise its option by providing C3 LABS and the C3 Members written notice of its intent to exercise the option. The C3 Members shall have three (3) days following the date of such notice to execute assignments of Interests totaling 30% of the then outstanding membership interests in C3 LABS in favor of EVIO California. If EVIO should elect to exercise its option within nine (9) months from the Closing Date, the exercise price for the 30% of Interests shall be $450,000.00, to be paid in cash or EVIO’s common stock, as agreed by the C3 Members. If EVIO does not exercise the option within nine (9) months from the Closing Date, the exercise price shall be set by mutual agreement between the parties or, if no such agreement can be reached, as determined by an independent third-party valuation by an appraiser agreed to by the parties.
C3 Labs, LLC [Member] | January 1, 2018 [Member] | Option Two [Member]
Option to purchase of additional interest, description			(b) 10% Option. Effective as of three (3) years after the Closing Date and terminating the date twenty four (24) months therefrom, the C3 Members hereby collectively grant EVIO the right to ratably purchase from the C3 Members an aggregate of 10% of the then outstanding Interests in C3 LABS (comprising the remaining Interests not owned by EVIO). EVIO may exercise its option by providing C3 LABS and the C3 Members written notice of its intent to exercise the option. The C3 Members shall have three (3) days following the date of such notice to execute assignments of Interests totaling 10% of the then outstanding membership interests in C3 LABS in favor of EVIO. Upon notice of its intent to exercise the option granted hereby, the exercise price shall be set by mutual agreement between the parties or, if no such agreement can be reached, as determined by an independent third-party valuation by an appraiser agreed to by the parties.
C3 Labs, LLC [Member] | January 1, 2018 to June 30, 2018 [Member]
Total revenues			$ 75,835

INDUSTRY SEGMENTS (Details)

INDUSTRY SEGMENTS (Details) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017	Sep. 30, 2017
Revenue	$ 634,338	$ 777,218	$ 2,313,514	$ 2,278,397
Total assets					$ (200,000)
Depreciation and amortization	30,705	14,001	63,796	22,135
Corporate [Member]
Revenue
Segment income (loss) from operations	(573,239)	(210,554)	(2,033,171)	(589,258)
Total assets	1,899,440	85,877	1,899,440	85,877
Capital expenditures
Depreciation and amortization
Consulting Services [Member]
Revenue	38,637	9,345	141,453	196,520
Segment income (loss) from operations	(1,083,993)	(197,546)	(2,059,269)	(192,898)
Total assets	372,224	240,459	372,224	240,459
Capital expenditures			1,038	(1,038)
Depreciation and amortization	4,075	5,975	11,246	17,922
Testing Services [Member]
Revenue	595,701	767,873	2,172,061	2,081,877
Segment income (loss) from operations	(653,134)	(91,472)	(1,247,926)	(390,590)
Total assets	11,497,993	3,644,591	11,497,993	3,644,591
Capital expenditures	(351,998)	(2,962)	(882,474)	(47,688)
Depreciation and amortization	191,500	63,056	410,304	171,839
Total Consolidated [Member]
Revenue	634,338	777,218	2,313,514	2,278,397
Segment income (loss) from operations	(2,310,366)	(499,572)	(5,340,366)	(1,172,746)
Total assets	13,769,657	3,970,927	13,769,657	3,970,927
Capital expenditures	(351,998)	(2,962)	(883,512)	(48,726)
Depreciation and amortization	$ 195,575	$ 69,031	$ 421,550	$ 189,761

STOCK OPTIONS AND WARRANTS (Det

STOCK OPTIONS AND WARRANTS (Details)	9 Months Ended
	Jun. 30, 2018$ / sharesshares
Number of Options
Number of options outstanding, beginning | shares	655,000
Number of Options, Granted | shares	4,268,049
Number of Options, Exercised | shares	(13,333)
Number of Options, Forfeited | shares	(70,000)
Number of Options, Expired | shares
Number of options outstanding, ending | shares	4,839,716
Weighted Average Exercise Price
Weighted average exercise price outstanding, beginning | $ / shares	$ 0.902
Weighted Average Exercise Price, Granted | $ / shares	0.795
Weighted Average Exercise Price, Exercised | $ / shares	0.600
Weighted Average Exercise Price, Forfeited | $ / shares	0.891
Weighted Average Exercise Price, Expired | $ / shares
Weighted average exercise price outstanding, ending | $ / shares	$ 0.809

STOCK OPTIONS AND WARRANTS (D59

STOCK OPTIONS AND WARRANTS (Details 1) - $ / shares	9 Months Ended
	Jun. 30, 2018	Sep. 30, 2017
Outstanding Number of Option Shares	4,839,716	655,000
Outstanding Weighted Average Exercise Price	$ 0.809	$ 0.902
Weighted Average Remaining Life (Years)	3 years 4 months 20 days
Exercisable Number of Option Shares	3,398,466
Exercisable Weighted Average Exercise Price	$ 0.761
0.400 [Member]
Outstanding Number of Option Shares	120,000
Outstanding Weighted Average Exercise Price	$ 0.400
Weighted Average Remaining Life (Years)	3 years 1 month 16 days
Exercisable Number of Option Shares	90,000
Exercisable Weighted Average Exercise Price	$ 0.400
0.500 [Member]
Outstanding Number of Option Shares	165,000
Outstanding Weighted Average Exercise Price	$ 0.500
Weighted Average Remaining Life (Years)	3 years 2 months 12 days
Exercisable Number of Option Shares	123,750
Exercisable Weighted Average Exercise Price	$ 0.500
0.600 [Member]
Outstanding Number of Option Shares	583,966
Outstanding Weighted Average Exercise Price	$ 0.600
Weighted Average Remaining Life (Years)	1 year 6 months 29 days
Exercisable Number of Option Shares	583,966
Exercisable Weighted Average Exercise Price	$ 0.600
0.650 [Member]
Outstanding Number of Option Shares	145,000
Outstanding Weighted Average Exercise Price	$ 0.650
Weighted Average Remaining Life (Years)	4 years 3 months 26 days
Exercisable Number of Option Shares	36,250
Exercisable Weighted Average Exercise Price	$ 0.650
0.800 [Member]
Outstanding Number of Option Shares	3,195,750
Outstanding Weighted Average Exercise Price	$ 0.800
Weighted Average Remaining Life (Years)	3 years 5 months 27 days
Exercisable Number of Option Shares	2,420,750
Exercisable Weighted Average Exercise Price	$ 0.800
1.100 [Member]
Outstanding Number of Option Shares	170,000
Outstanding Weighted Average Exercise Price	$ 1.100
Weighted Average Remaining Life (Years)	4 years 11 months 19 days
Exercisable Number of Option Shares	42,500
Exercisable Weighted Average Exercise Price	$ 1.100
1.260 [Member]
Outstanding Number of Option Shares	230,000
Outstanding Weighted Average Exercise Price	$ 1.260
Weighted Average Remaining Life (Years)	4 years 4 days
Exercisable Number of Option Shares	57,500
Exercisable Weighted Average Exercise Price	$ 1.260
1.280 [Member]
Outstanding Number of Option Shares	150,000
Outstanding Weighted Average Exercise Price	$ 1.280
Weighted Average Remaining Life (Years)	4 years 9 months 18 days
Exercisable Number of Option Shares	18,750
Exercisable Weighted Average Exercise Price	$ 1.280
1.300 [Member]
Outstanding Number of Option Shares	10,000
Outstanding Weighted Average Exercise Price	$ 1.300
Weighted Average Remaining Life (Years)	3 years 3 months 22 days
Exercisable Number of Option Shares	5,000
Exercisable Weighted Average Exercise Price	$ 1.300
1.386 [Member]
Outstanding Number of Option Shares	60,000
Outstanding Weighted Average Exercise Price	$ 1.386
Weighted Average Remaining Life (Years)	4 years 4 days
Exercisable Number of Option Shares	15,000
Exercisable Weighted Average Exercise Price	$ 1.386
1.666 [Member]
Outstanding Number of Option Shares	10,000
Outstanding Weighted Average Exercise Price	$ 1.666
Weighted Average Remaining Life (Years)	4 years 1 month 2 days
Exercisable Number of Option Shares	2,500
Exercisable Weighted Average Exercise Price	$ 1.666

STOCK OPTIONS AND WARRANTS (D60

STOCK OPTIONS AND WARRANTS (Details 2)	9 Months Ended
	Jun. 30, 2018
Expected dividend yield	0.00%
Minimum [Member]
Expected term of options granted	4 years 11 months 23 days
Expected volatility	251.00%
Risk-free interest rate	2.01%
Maximum [Member]
Expected term of options granted	5 years
Expected volatility	256.00%
Risk-free interest rate	2.25%

STOCK OPTIONS AND WARRANTS (D61

STOCK OPTIONS AND WARRANTS (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Stock Options And Warrants Details Narrative Abstract
Stock option expense	$ 321,898	$ 14,133	$ 1,389,666	$ 63,917
Unrecognized stock based compensation expense			$ 1,198,583

COMMETTMENTS AND CONTINGECIES62

COMMETTMENTS AND CONTINGECIES (Details)	Sep. 30, 2017USD ($)
Year ending September 30,
2,018	$ 168,657
2,019	639,375
2,020	609,812
2,021	417,809
2,022	291,974
2,023	132,660
Total	$ 2,260,290

COMMETTMENTS AND CONTINGECIES63

COMMETTMENTS AND CONTINGECIES (Details Narrative)	12 Months Ended
	Sep. 30, 2017USD ($)
Commettments And Contingecies Details Narrative Abstract
Purchase of software license	$ 200,000
Impairment loss	$ (200,000)

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative) - USD ($)	9 Months Ended
	Jun. 30, 2018	Jun. 27, 2018	Jun. 30, 2017	Aug. 01, 2018	Sep. 30, 2017
Common stock, shares issued	19,719,903				10,732,922
Common stock, value	$ 1,972				$ 1,073
Common stock shares issued for services, value	$ 450,016
Debt instrument converted amount shares issued	670,271
Subsequent Event [Member]
Common stock shares issued for services, shares	5,000
Common stock shares issued for services, value	$ 5,450
Debt instrument converted amount	$ 125,000
Debt instrument converted amount shares issued	208,332
Subsequent Event [Member] | Promissory Note [Member]
Promissory note issued				$ 330,000
Conversion price				$ 0.60
Subsequent Event [Member] | Promissory Note [Member] | August 1, 2018 [Member]
Interest rate of secured promissory note	8.00%
Due date	Oct. 1, 2018
Proceeds from promissory note	$ 3,000,000
Original issue discount	$ 30,000
Subsequent Event [Member] | Purchase and Sale Agreement Member
Business acquisition purchase price		$ 1,150,000
Payment due upon execution of the PSA		25,000
Escrowed amount PSA		475,000
Business acquisition purchase price payable through secured promissory note		$ 650,000
Interest rate of secured promissory note		8.00%
Subsequent Event [Member] | Asset Purchase Agreement [Member] | MRX Labs LLC [Member]
Purchase agreement description		Greenhaus acquired certain tangible and intangible assets of MRX, including but limited to (i) furniture, (ii) fixtures, (iii) client and vender contracts, (iv) inventory, (v) goodwill, (vi) ownership rights to any copyrightable works, including all related copyright registrations, (vii) know-how or other trade secrets, whether or not reduced to practice, (viii) licenses, options to license and other contractual rights to use intellectual property, (ix) computer and electronic data processing programs and software programs, (x) equipment, (xi) customer lists, (xii) “know-how “ and proprietary information and trade secrets relating to the MRX’s business operations, (xiii) manufacturers’ warranties (including pending warranty claims) and manuals relating to the purchased assets (xiv) an irrevocable license to use the tradename “MRX Labs” for six months, (xv) certain assets specifically listed in Exhibit A of the APA and (xvi) MRX’s books and records relating to the foregoing (the “Assets”).
Purchase price of assets		$ 1,500,000
Payable as a cashierÂ’s check or wire transfer		750,000
Payment in promissory note		$ 750,000